Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3036782	pf-gluk	mmol/l (mmol/l)	3726	4884	0.14%
3036782	pf-gluk	— (—)	412	442	100.00%	Distribution not available
3036782	pf-gluk	mmol/l____ (mmol/l)	76	95	0.00%
3036782	pf-gluk	mmol/L (mmol/l)	24	29	0.00%
3036782	pf-gluk	MMOL/L (mmol/l)	14	17	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Bacterial infection, other or unspecified

924

1927

4.14

314.87

1.4

1.3

6.38

6.23

mmol/l

0.68

861

1805

Asthma, excluding more controls

524

271

10.02

312.88

1.3

1.1

6.21

6.42

mmol/l

0.61

478

247

Asthma, unspecified (mode)

476

412

8.44

311.28

1.4

1.1

6.33

6.79

mmol/l

2.00

436

378

Pneumonias (Asthma/COPD co-morbidities)

1535

1936

5.28

307.65

1.4

1.3

6.34

6.16

mmol/l

1.11

1420

1812

Bacterial infection, other or unspecified, including avohilmo

983

1977

4.16

307.65

1.4

1.3

6.33

6.24

mmol/l

0.39

916

1846

Pyothorax

441

197

29.55

307.65

1.6

1.4

4.37

6.44

mmol/l

16.29

369

192

Pneumonia, organism unspecified

1469

1854

5.54

307.65

1.4

1.3

6.37

6.16

mmol/l

1.33

1363

1740

Other pleural conditions

993

244

51.60

307.65

1.6

1.2

5.95

7.10

mmol/l

5.03

936

228

Pleural effusion

1777

389

60.23

307.65

1.5

1.2

5.93

6.97

mmol/l

7.25

1693

354

Lung cancer and mesothelioma

697

181

35.05

307.65

1.4

1.1

5.77

7.09

mmol/l

7.89

666

161

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1334

1549

5.13

307.65

1.4

1.3

6.33

6.16

mmol/l

0.98

1235

1456

Any death

1142

1578

5.21

307.65

1.4

1.3

6.39

6.30

mmol/l

0.38

1077

1456

1334

1549

5.13

307.65

1.4

1.3

6.33

6.16

mmol/l

0.98

1235

1456

COPD differential diagnosis

744

433

8.71

307.65

1.4

1.1

6.20

6.75

mmol/l

3.34

696

399

COPD (mode)

457

259

14.11

307.65

1.3

1.1

6.42

7.04

mmol/l

2.42

421

231

Other pulmonary diagnosis

756

430

8.92

307.65

1.4

1.1

6.16

6.75

mmol/l

3.75

705

396

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1532

1963

5.30

307.65

1.4

1.3

6.33

6.17

mmol/l

0.96

1417

1838

Dyspnoea

1264

2638

3.51

307.65

1.4

1.3

6.41

6.22

mmol/l

1.33

1199

2438

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

746

772

8.41

307.65

1.4

5.77

6.59

mmol/l

8.12

709

711

All-cause Heart Failure

1134

1659

4.89

307.65

1.4

1.3

7.14

5.74

mmol/l

34.38

1078

1527

Influenza and pneumonia

1495

1889

4.97

307.65

1.4

1.3

6.31

6.15

mmol/l

1.00

1383

1773

Other bacterial diseases

1263

2364

3.59

307.65

1.4

1.3

6.46

6.16

mmol/l

2.36

1177

2207

Heart failure,strict

1044

1251

6.01

307.65

1.4

1.3

7.14

5.52

mmol/l

41.86

992

1152

ILD differential diagnosis

744

433

8.71

307.65

1.4

1.1

6.20

6.75

mmol/l

3.34

696

399

Excluding asthma or asthma-COPD overlap

744

430

8.77

307.65

1.4

1.1

6.19

6.75

mmol/l

3.40

695

396

Suppurative and necrotic conditions of lower respiratory tract

484

242

25.00

307.65

1.5

1.4

4.51

6.42

mmol/l

15.33

410

231

Other diseases of pleura

2364

1021

22.21

307.65

1.5

1.2

6.06

6.82

mmol/l

9.95

2235

933

All pneumoniae

1530

1934

5.23

307.65

1.4

1.3

6.33

6.17

mmol/l

1.01

1415

1810

Heart failure, not strict

1185

1578

5.16

307.65

1.4

1.3

6.97

5.61

mmol/l

33.94

1114

1451

Malignant neoplasm of respiratory system and intrathoracic organs

669

714

8.22

307.65

1.4

5.70

6.61

mmol/l

8.79

635

654

Heart failure, strict

1162

1683

4.94

307.65

1.4

1.3

7.14

5.75

mmol/l

34.37

1104

1548

Asthma, unspecified (mode), excluding more controls

458

259

12.81

307.65

1.4

1.1

6.29

6.45

mmol/l

0.37

419

235

Malignant neoplasm of bronchus and lung, including Hilmo

590

716

7.21

307.65

1.3

1.4

6.02

6.64

mmol/l

4.11

561

657

Other medical care

1019

1669

5.28

307.65

1.4

1.3

6.15

6.26

mmol/l

0.53

975

1542

Non-small cell lung cancer, including Hilmo

448

566

7.83

306.65

1.3

1.4

5.89

6.66

mmol/l

4.88

423

519

Later onset COPD, excluding more controls

339

197

13.52

305.12

1.4

1.1

6.31

7.16

mmol/l

3.48

312

174

Malignant neoplasm of bronchus and lung

511

642

6.97

301.55

1.3

1.4

5.98

6.65

mmol/l

4.19

486

590

Asthma (only as main-diagnosis), excluding more controls

482

271

9.92

300.32

1.3

1.1

6.21

6.42

mmol/l

0.58

443

247

Other bacterial diseases, including avohilmo

1218

2253

3.42

289.85

1.4

1.3

6.39

6.15

mmol/l

1.67

1133

2101

Heart failure and antihypertensive medication

477

414

7.72

273.52

1.5

1.3

7.22

5.50

mmol/l

19.30

455

376

Bacterial pneumoniae

649

1214

4.80

269.99

1.4

1.3

6.52

6.24

mmol/l

1.21

592

1140

Bacterial pneumonia, not elsewhere classified

626

1159

4.85

263.74

1.4

1.3

6.53

6.22

mmol/l

1.36

571

1088

Renal tubulo-interstitial diseases

1121

2553

3.26

261.47

1.4

1.3

6.96

5.98

mmol/l

17.90

1057

2366

Asthma

561

428

6.82

260.38

1.3

1.1

6.21

6.75

mmol/l

3.21

513

394

Non-ischemic cardiomyopathy

600

957

5.13

257.84

1.4

1.3

6.74

5.63

mmol/l

14.21

577

885

Renal failure

891

2137

3.64

254.35

1.4

1.3

7.30

6.05

mmol/l

21.86

837

1991

Non-small cell lung cancer

336

409

8.62

254.10

1.3

1.4

5.89

6.67

mmol/l

3.62

319

375

Oxycodone

720

1501

4.20

251.30

1.3

6.04

6.41

mmol/l

2.43

675

1404

Diseases of the respiratory system

553

415

6.75

250.36

1.4

1.1

6.21

6.77

mmol/l

3.29

519

386

Septicaemia

734

1694

4.04

248.46

1.4

1.3

6.84

6.20

mmol/l

5.45

681

1589

Explicit Sepsis, including avohilmo

765

1810

3.92

247.69

1.4

1.3

6.82

6.03

mmol/l

8.46

712

1690

Bacterial Sepsis

822

1833

3.79

247.18

1.4

1.3

6.96

6.02

mmol/l

12.64

762

1713

Asthma (only as main-diagnosis)

511

428

6.73

245.52

1.3

1.1

6.22

6.75

mmol/l

2.81

471

394

All chronic kidney diseases

873

1956

3.63

244.45

1.4

1.3

7.23

5.95

mmol/l

21.54

827

1810

Explicit Sepsis

750

1791

3.90

241.66

1.4

1.3

6.83

6.03

mmol/l

8.25

697

1673

Non-small cell lung cancer, adenocarcinoma

239

208

12.51

235.26

1.3

5.78

6.81

mmol/l

3.51

224

190

Persons encountering health services for specific procedures and health care

1151

2257

3.04

224.64

1.4

1.3

6.33

6.18

mmol/l

0.93

1074

2077

Asthma (mode)

505

433

6.18

218.63

1.4

1.1

6.18

6.75

mmol/l

3.28

464

399

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

958

2714

3.12

217.88

1.4

1.3

6.13

6.41

mmol/l

2.14

896

2531

Other septicaemia, including avohilmo

662

1623

3.92

216.52

1.4

1.3

6.92

6.19

mmol/l

6.38

617

1520

Abnormal findings on diagnostic imaging of lung

808

2304

3.39

214.27

1.4

1.3

6.01

6.39

mmol/l

3.21

755

2149

Heart failure and coronary heart disease

795

1572

3.64

212.94

1.5

1.3

7.28

6.04

mmol/l

20.42

752

1465

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1156

2750

2.87

212.27

1.4

1.3

6.58

6.15

mmol/l

4.55

1088

2546

Other septicaemia

648

1601

3.90

211.32

1.4

1.3

6.93

6.18

mmol/l

6.52

603

1500

Implicit bacterial Sepsis

722

1717

3.69

211.03

1.4

1.3

7.12

6.04

mmol/l

14.19

673

1602

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

149

27.94

210.27

1.7

1.3

4.72

6.95

mmol/l

6.13

142

Implicit bacterial Sepsis, including avohilmo

760

1810

3.57

209.94

1.4

1.3

7.12

6.02

mmol/l

15.63

709

1692

Heart failure and bmi 25plus

564

809

4.77

209.72

1.4

1.3

7.18

5.88

mmol/l

16.82

534

731

Malignant neoplasm of heart, mediastinum and pleura

133

36.75

203.38

1.7

1.4

4.60

6.66

mmol/l

4.34

128

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

426

827

5.14

197.80

1.3

1.4

5.97

6.59

mmol/l

3.87

404

759

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

359

627

5.93

196.19

1.3

1.4

5.94

6.55

mmol/l

2.96

337

575

Abnormalities of breathing

950

1749

3.14

193.30

1.4

1.3

6.33

6.07

mmol/l

1.75

883

1615

All kidney diseases

1071

2561

2.83

192.35

1.4

1.3

6.81

5.95

mmol/l

14.34

1010

2370

Implicit Sepsis

929

2311

3.00

189.45

1.4

1.3

7.05

6.01

mmol/l

17.95

868

2150

Other heart diseases, wide

828

1548

3.27

183.08

1.4

1.3

6.62

5.65

mmol/l

15.82

778

1410

Chronic kidney disease

616

1678

3.63

180.92

1.5

1.3

7.37

6.03

mmol/l

17.13

579

1555

COPD/asthma related infections

950

1549

3.10

180.87

1.4

1.3

6.33

6.16

mmol/l

0.84

879

1456

COPD/asthma/ILD related infections

950

1549

3.10

180.87

1.4

1.3

6.33

6.16

mmol/l

0.84

879

1456

Early onset COPD, excluding more controls

198

189

10.65

180.81

1.3

1.1

6.62

6.87

mmol/l

0.39

184

172

Other heart diseases

420

533

5.18

170.79

1.4

1.2

6.57

5.49

mmol/l

9.61

389

485

Bacterial pneumonia (organism specified)

689

1960

3.24

168.48

1.4

1.3

6.55

6.25

mmol/l

1.48

628

1837

Malignant neoplasm of mesothelium and soft tissue

157

124

13.89

164.41

1.6

1.4

4.85

6.83

mmol/l

8.47

152

115

Valvular heart disease excluding rheumatic fever

556

1050

3.84

163.63

1.4

1.3

6.67

5.64

mmol/l

12.99

524

946

Pneumothorax

164

139

12.41

163.28

1.5

1.2

5.37

7.12

mmol/l

4.07

151

130

Non-small cell lung cancer, adenocarcinoma, helper endpoint

239

336

7.71

163.14

1.3

1.4

5.78

6.42

mmol/l

1.70

224

315

Dialysis, with operation codes

286

487

6.14

161.00

1.5

1.3

7.27

5.84

mmol/l

9.51

271

451

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

189

202

9.96

160.75

1.5

1.3

4.90

6.80

mmol/l

12.60

181

186

Implicit Sepsis, including avohilmo

908

2368

2.77

159.60

1.4

1.3

7.03

5.99

mmol/l

17.68

847

2202

Non-rheumatic valve diseases

550

1049

3.80

159.50

1.4

1.3

6.68

5.64

mmol/l

13.18

519

945

Malignant neoplasm

808

1567

3.05

158.47

1.4

1.3

5.90

6.58

mmol/l

8.28

759

1444

Liquid cancers, including Hilmo

478

1081

3.97

157.30

1.4

1.3

6.29

6.61

mmol/l

1.60

451

997

Malignant neoplasm

802

1565

3.03

155.69

1.4

1.3

5.90

6.58

mmol/l

8.18

753

1442

Malignant neoplasm, including Hilmo

806

1573

3.01

154.68

1.4

1.3

5.99

6.57

mmol/l

5.47

754

1451

Malignant neoplasm, wide definition

807

1579

3.00

154.04

1.4

1.3

6.00

6.57

mmol/l

5.36

755

1456

Fever of other and unknown origin

685

1968

3.05

150.74

1.4

1.3

6.21

mmol/l

0.02

639

1830

Solid cancers

785

1547

3.00

150.24

1.4

1.3

5.86

6.58

mmol/l

9.18

737

1427

Acute renal failure

425

1082

4.05

147.45

1.4

1.3

7.38

5.98

mmol/l

15.51

400

993

Atrial fibrillation and flutter

328

379

5.67

145.28

1.5

1.2

6.65

5.43

mmol/l

10.32

311

342

Solid cancers, including Hilmo

785

1568

2.94

145.07

1.4

1.3

5.93

6.58

mmol/l

6.66

733

1446

Nephropathy related operations

276

510

5.66

142.61

1.5

1.3

7.31

6.12

mmol/l

5.94

261

472

Any event in cancer register

812

1697

2.82

139.29

1.4

1.3

5.93

6.55

mmol/l

7.14

759

1570

Anaemias

199

127

10.17

138.02

1.4

1.2

6.97

5.06

mmol/l

9.68

190

113

Diseases of arteries, arterioles and capillaries (FINNGEN)

275

308

6.27

137.83

1.4

1.3

6.86

5.43

mmol/l

8.64

257

274

Condition for Implicit Sepsis (Organ dysfunction codes)

878

2364

2.60

135.68

1.4

1.3

7.03

5.97

mmol/l

17.61

817

2201

Erysipelas, including avohilmo

773

2129

2.72

132.78

1.4

1.3

6.66

6.18

mmol/l

3.92

719

1988

Other diseases of pericardium

137

122

12.02

132.53

1.6

1.2

6.75

5.80

mmol/l

1.56

126

115

Atrial fibrillation and flutter with reimbursement

287

312

5.90

130.40

1.4

1.2

6.63

5.38

mmol/l

8.50

272

279

First line medication for Crohn's disease

1043

2344

2.41

129.16

1.4

1.3

6.07

6.39

mmol/l

2.82

971

2180

Liquid cancers

388

971

3.85

125.14

1.4

6.33

6.60

mmol/l

1.07

371

894

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

859

2333

2.51

122.86

1.4

1.3

6.87

5.96

mmol/l

13.86

799

2169

Non-invasive ventilation

267

455

5.14

120.59

1.4

1.3

6.65

5.18

mmol/l

14.23

238

420

GASTRO-related operations

603

969

3.14

117.97

1.4

1.3

6.27

6.22

mmol/l

0.14

572

900

Any gastric operation

603

969

3.14

117.97

1.4

1.3

6.27

6.22

mmol/l

0.14

572

900

Aplastic and other anaemias

662

2305

2.67

114.96

1.4

6.75

6.25

mmol/l

3.68

626

2147

Cardiomyopathy

252

520

4.96

114.16

1.3

6.72

5.50

mmol/l

6.55

240

472

Non-allergic asthma (mode), excluding more controls

122

115

10.62

111.19

1.4

1.1

6.21

6.60

mmol/l

0.64

116

100

Respiratory insufficiency

111

12.09

109.75

1.5

1.1

6.63

6.97

mmol/l

0.44

103

Other anaemias

619

2215

2.66

107.08

1.4

6.78

6.26

mmol/l

3.67

586

2060

Other and unspecified anaemias

612

2207

2.64

104.94

1.4

6.82

6.26

mmol/l

4.05

579

2052

Erysipelas

615

2033

2.64

103.50

1.4

1.3

6.68

6.21

mmol/l

3.24

574

1899

Covid-19 confirmed case

519

1866

2.82

102.48

1.4

6.61

6.24

mmol/l

1.94

497

1723

Care involving dialysis

169

270

6.53

101.57

1.5

1.3

7.43

6.32

mmol/l

2.97

159

249

Other disorders of fluid, electrolyte and acid-base balance

454

1438

3.03

100.19

1.4

1.3

6.77

6.12

mmol/l

4.49

423

1338

Cardiac arrhythmias

448

912

3.17

97.08

1.4

1.2

6.41

5.23

mmol/l

18.66

425

835

Oral corticosteroids

1001

2762

2.14

96.78

1.4

1.3

6.23

6.30

mmol/l

0.31

928

2577

Codes for special purposes

607

2432

2.50

94.57

1.4

1.3

6.55

6.22

mmol/l

1.89

579

2248

Ascites

179

325

5.76

94.47

1.4

6.20

6.32

mmol/l

0.20

167

301

Provisional assignment of new diseases of uncertain etiology

606

2432

2.50

94.10

1.4

1.3

6.54

6.22

mmol/l

1.81

578

2248

Hypertensive heart and/or renal disease

382

843

3.37

93.92

1.4

1.3

7.09

5.63

mmol/l

15.62

366

791

Diseases of arteries, arterioles and capillaries

776

2544

2.26

90.29

1.4

7.02

6.17

mmol/l

10.64

720

2374

ILD medications: prednisolone, methylprednisolone, prednisone

976

2592

2.11

89.59

1.4

1.3

6.22

6.28

mmol/l

0.27

906

2416

COPD

597

1960

2.51

89.30

1.4

6.38

6.31

mmol/l

0.23

549

1831

ILD medications

993

2604

2.07

86.25

1.4

1.3

6.21

6.28

mmol/l

0.30

922

2427

Acute tubulo-interstitial nephritis

628

2236

2.39

86.05

1.3

6.75

5.99

mmol/l

7.57

587

2082

Haemorrhage from respiratory passages

418

1289

2.91

85.24

1.3

6.38

6.12

mmol/l

1.05

399

1189

Pulmonary heart disease, diseases of pulmonary circulation

451

1667

2.75

84.87

1.4

6.13

6.33

mmol/l

0.78

419

1543

Implicit viral Sepsis, including avohilmo

384

1304

2.98

84.15

1.4

1.3

7.23

6.02

mmol/l

9.77

360

1213

Cerebrovascular diseases (FINNGEN)

245

402

4.32

84.02

1.4

1.2

6.69

5.47

mmol/l

7.35

236

362

Continuous positive airway pressure

205

368

4.72

82.94

1.3

7.04

5.09

mmol/l

10.19

186

337

Other chronic obstructive pulmonary disease

570

1924

2.46

81.91

1.3

1.4

6.43

6.30

mmol/l

0.48

526

1798

Undetermined asthma, excluding more controls

11.01

79.72

1.4

1.1

5.91

6.59

mmol/l

1.11

Inflammatory bowel disease treatment related agents

996

2782

2.00

79.58

1.4

1.3

6.18

6.29

mmol/l

0.56

927

2596

Asthma-related pneumonia

476

1862

2.58

79.27

1.3

6.32

6.29

mmol/l

0.08

433

1736

Asthma-related pneumonia or sepsis

476

1865

2.58

79.00

1.3

6.32

6.29

mmol/l

0.08

433

1739

Asthma, hospital admissions 3, pneumonia

476

1865

2.58

79.00

1.3

6.32

6.29

mmol/l

0.08

433

1739

Cardiomyopathy (excluding other)

179

379

4.84

78.92

1.3

6.85

5.53

mmol/l

5.20

169

343

Pulmonary embolism

407

1497

2.77

77.39

1.4

6.04

6.33

mmol/l

1.19

376

1382

Cardiovascular diseases (excluding rheumatic etc)

351

616

3.28

77.25

1.4

1.2

6.22

5.45

mmol/l

5.52

323

560

AV-block

238

526

3.94

77.04

1.5

1.3

6.91

5.49

mmol/l

9.33

230

474

Pulmonary heart disease

407

1501

2.76

76.99

1.4

6.04

6.35

mmol/l

1.30

376

1386

Other chronic obstructive pulmonary disease, including avohilmo

649

2394

2.25

76.76

1.3

1.4

6.39

6.31

mmol/l

0.28

599

2236

Conduction disorders

312

769

3.29

76.57

1.5

1.3

6.74

5.54

mmol/l

9.63

299

701

Certain infectious and parasitic diseases

761

1735

2.21

76.46

1.4

1.3

6.31

6.09

mmol/l

1.21

713

1620

Cardiomyopathies, Primary/intrinsic

168

353

4.87

74.77

1.3

6.90

5.52

mmol/l

5.34

158

320

Non-allergic asthma (mode)

122

188

6.49

74.42

1.4

1.1

6.21

6.77

mmol/l

1.30

116

169

Metabolic disorders

834

2439

2.06

74.30

1.4

1.3

6.72

6.09

mmol/l

6.72

770

2268

DVT of lower extremities and pulmonary embolism

515

2159

2.41

73.73

1.3

1.4

6.09

6.32

mmol/l

0.98

475

2013

Malaise and fatigue

539

1790

2.39

72.85

1.3

6.50

6.21

mmol/l

1.27

500

1666

Venous thromboembolism

615

2696

2.22

72.67

1.3

1.4

6.14

6.38

mmol/l

1.15

570

2518

L04AD Calcineurin inhibitors

157

322

5.01

71.98

1.5

1.4

7.04

6.04

mmol/l

2.69

151

298

Transplanted organ and tissue status

157

323

5.01

71.78

1.5

1.4

7.19

6.10

mmol/l

3.24

152

299

COPD, hospital admissions

575

2137

2.30

71.53

1.4

6.42

6.30

mmol/l

0.45

532

1996

COPD, early/later onset

578

2153

2.28

70.84

1.3

1.4

6.43

6.29

mmol/l

0.51

534

2010

ILD, hospital admission 2, with pulmonary infections

158

331

4.91

70.70

1.5

1.3

6.76

6.23

mmol/l

1.10

146

311

COPD, hospital admissions 3, with asthma pneumonia sepsis

422

1400

2.63

70.26

1.3

1.4

6.56

6.33

mmol/l

0.75

386

1302

All influenza

255

759

3.40

70.03

1.4

1.3

6.90

6.18

mmol/l

3.05

235

708

Tramadol

662

1819

2.20

69.49

1.4

1.3

6.42

6.34

mmol/l

0.28

617

1698

ILD, hospital admissions 3, with pneumonia sepsis

150

306

5.06

69.35

1.5

1.3

6.72

6.34

mmol/l

0.67

140

288

Hypertensive Heart Disease

322

808

3.07

69.30

1.4

1.3

7.09

5.63

mmol/l

13.00

305

759

COPD, hospital admission 2, with asthma infections

459

1604

2.50

69.26

1.3

1.4

6.58

6.30

mmol/l

1.11

421

1495

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

195

493

4.04

68.43

1.5

1.4

6.23

6.59

mmol/l

1.09

181

446

Viral pneumonia

162

356

4.64

68.23

1.5

1.3

6.92

6.31

mmol/l

1.58

153

336

Complications of surgical and medical care, not elsewhere classified

899

3131

1.93

67.93

1.4

1.3

6.44

6.25

mmol/l

1.18

851

2905

Other arrhythmias

457

1378

2.49

66.92

1.4

1.3

6.40

5.68

mmol/l

7.32

435

1255

Opioids

753

1871

2.09

66.70

1.4

1.3

6.25

6.31

mmol/l

0.22

701

1745

Secondary uncertain malignant neoplasm

183

451

4.15

66.55

1.4

6.46

6.62

mmol/l

0.28

176

409

Implicit viral Sepsis

272

871

3.18

66.53

1.4

1.3

7.34

6.01

mmol/l

8.50

260

805

Viral Sepsis

272

872

3.17

66.40

1.4

1.3

7.34

6.01

mmol/l

8.49

260

806

Valvular operations

180

439

4.18

66.31

1.5

1.3

6.61

5.44

mmol/l

6.23

172

397

Extracorporeal dialysis

136

267

5.34

66.04

1.5

1.4

7.20

6.32

mmol/l

2.41

128

250

Symptoms and signs involving the circulatory and respiratory systems

730

1751

2.10

64.97

1.4

1.3

6.40

6.07

mmol/l

2.28

682

1617

COPD related to multimorbidity

521

1944

2.30

64.88

1.4

6.60

6.31

mmol/l

1.29

481

1811

Any reimbursement code in KELA

311

485

3.23

63.91

1.4

1.2

6.39

5.44

mmol/l

6.58

290

444

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

268

507

3.35

63.25

1.3

1.2

6.17

5.53

mmol/l

3.01

249

462

Hypertensive diseases (excluding secondary)

295

539

3.20

63.17

1.5

1.2

6.64

5.49

mmol/l

7.71

268

491

ILD medications: immunosuppressive drugs

539

2219

2.22

63.06

1.4

1.3

6.22

6.28

mmol/l

0.15

503

2061

Bleeding

787

2843

1.95

62.62

1.4

1.3

6.66

6.24

mmol/l

3.33

735

2643

Percutaneous Coronary Intervention

693

2053

2.07

62.28

1.4

1.3

6.90

5.97

mmol/l

13.53

643

1907

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

814

2667

1.94

62.00

1.4

1.3

6.62

6.08

mmol/l

6.32

762

2465

Pleural plaque

128

251

5.23

61.86

1.3

1.2

5.86

7.08

mmol/l

3.83

122

231

General symptoms and signs

828

2132

1.96

60.98

1.3

6.35

6.20

mmol/l

0.74

771

1985

Paroxysmal tachycardia

170

336

4.25

60.85

1.4

1.2

6.64

5.49

mmol/l

4.81

159

304

Pacemaker

490

2038

2.27

60.30

1.4

6.98

6.23

mmol/l

7.24

471

1893

Presence of cardiac and vascular implants and grafts

551

1867

2.20

60.05

1.4

1.3

7.02

6.19

mmol/l

8.25

529

1732

Emergency coronary revascularization (for ACS)

770

2392

1.96

59.47

1.4

1.3

6.84

6.07

mmol/l

10.03

710

2225

Infections, IBD-co-morbidities

192

345

3.97

59.27

1.5

1.3

6.52

5.42

mmol/l

4.13

178

321

Non-Hodgkin lymphoma, all, including Hilmo

169

431

4.01

58.70

1.4

6.16

6.63

mmol/l

1.44

162

392

Glomerular diseases

247

807

3.12

58.57

1.4

7.77

6.21

mmol/l

8.38

233

750

Coronary revascularization (ANGIO or CABG)

682

2053

2.03

58.57

1.4

1.3

6.89

5.97

mmol/l

13.00

632

1907

Allergic asthma (mode), excluding more controls

149

6.39

58.15

1.2

1.1

6.12

6.36

mmol/l

0.35

135

malignant neoplasm of female genital organs, including Hilmo

159

368

4.18

58.00

1.3

5.56

6.87

mmol/l

7.13

152

341

Neoplasms

484

1077

2.37

57.96

1.4

1.3

6.04

6.35

mmol/l

1.52

455

990

Peripheral artery disease

544

2011

2.16

57.95

1.4

7.44

6.15

mmol/l

15.46

504

1880

Explicit bacterial Sepsis, including avohilmo

166

428

3.97

56.85

1.3

6.50

6.07

mmol/l

1.00

153

398

Primary_lymphoid and hematopoietic malignant neoplasms

316

1210

2.66

55.76

1.5

1.4

6.24

6.37

mmol/l

0.39

304

1112

Iron deficiency anaemia

474

2128

2.21

55.65

1.4

1.3

6.70

6.24

mmol/l

3.06

443

1984

Malignant neoplasm of digestive organs, including Hilmo

383

1144

2.48

55.45

1.3

6.28

6.66

mmol/l

1.60

359

1051

Undetermined asthma

124

6.92

55.31

1.4

1.1

5.91

6.80

mmol/l

2.10

111

Other CVD (FINNGEN)

128

194

5.12

55.13

1.5

1.2

6.56

5.36

mmol/l

3.02

118

174

Asthma, hospital admission 2, infections

562

2686

2.06

54.96

1.3

6.31

6.28

mmol/l

0.11

514

2510

Asthma-related infections

562

2686

2.06

54.96

1.3

6.31

6.28

mmol/l

0.11

514

2510

Care involving use of rehabilitation procedures

498

2093

2.15

54.36

1.4

1.3

6.55

6.23

mmol/l

1.53

459

1924

Hypo-osmolality and hyponatraemia

240

798

3.04

54.33

1.4

1.3

6.55

6.20

mmol/l

1.01

224

736

Unspecified kidney failure

181

512

3.63

54.33

1.3

1.4

7.26

6.10

mmol/l

3.28

171

474

Hard cardiovascular diseases

670

2003

1.99

54.02

1.4

1.3

6.83

5.93

mmol/l

10.24

624

1856

Explicit bacterial Sepsis

161

423

3.90

53.72

1.3

6.49

6.06

mmol/l

0.95

148

393

Ischemic heart diseases

686

2090

1.97

53.68

1.4

1.3

6.88

5.98

mmol/l

12.41

635

1942

Atherosclerosis, excluding cerebral and coronary sclerosis

517

1931

2.13

52.91

1.4

7.36

6.14

mmol/l

13.33

479

1803

Complications of procedures, not elsewhere classified

712

3059

1.89

52.63

1.4

1.3

6.35

6.27

mmol/l

0.33

669

2838

Major coronary heart disease event

713

2231

1.92

52.47

1.4

1.3

6.90

6.01

mmol/l

12.64

659

2074

Glomerular disorders in diseases classified elsewhere

180

527

3.50

51.25

1.4

8.46

6.18

mmol/l

10.87

168

493

Other respiratory disorders and diseases

290

1112

2.66

51.12

1.5

1.4

6.60

6.32

mmol/l

0.84

266

1025

Other diseases of the respiratory system

290

1112

2.66

51.12

1.5

1.4

6.60

6.32

mmol/l

0.84

266

1025

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

402

1163

2.35

50.72

1.3

6.27

6.64

mmol/l

1.37

375

1070

Pain in throat and chest

592

1738

2.03

50.42

1.3

6.36

6.08

mmol/l

1.61

547

1606

Complications of medical and surgical care

665

3185

1.89

50.31

1.4

1.3

6.50

6.29

mmol/l

1.03

626

2961

Type 2 diabetes, wide definition

696

2320

1.90

50.30

1.4

1.3

7.93

5.57

mmol/l

49.85

647

2159

Cardiovascular diseases

291

544

2.85

50.12

1.4

1.2

6.22

5.45

mmol/l

4.39

269

496

Malignant neoplasm of breast, HER2-negative

259

573

2.94

49.90

1.3

1.2

6.30

6.78

mmol/l

2.27

248

530

Polyarthropathies

630

2077

1.96

49.86

1.4

1.3

6.19

6.36

mmol/l

0.79

590

1932

Chronic lower respiratory diseases

943

2856

1.75

49.71

1.4

1.3

6.27

6.26

mmol/l

0.04

868

2666

Parasetamol

524

1242

2.14

49.44

1.4

1.3

6.27

6.22

mmol/l

0.15

493

1159

Malignant neoplasm of breast

258

574

2.92

49.21

1.3

1.2

6.28

6.78

mmol/l

2.39

247

531

Codeine

664

1861

1.94

48.80

1.3

6.39

6.31

mmol/l

0.27

616

1735

Other malignant neoplasms of skin (=non-melanoma skin cancer)

387

1129

2.35

48.66

1.3

6.11

6.62

mmol/l

2.78

360

1039

Major coronary heart disease event excluding revascularizations

576

1915

2.00

48.44

1.4

1.3

7.14

6.02

mmol/l

13.76

532

1779

Nutritional anaemias

523

2498

2.01

48.15

1.4

1.3

6.73

6.25

mmol/l

3.53

488

2334

Hypertension, essential

536

1468

2.07

48.04

1.4

1.3

6.73

5.66

mmol/l

10.53

493

1366

Basal cell carcinoma, including Hilmo

388

1137

2.33

48.03

1.3

6.07

6.62

mmol/l

3.27

360

1045

Malignant neoplasm of skin, including Hilmo

415

1238

2.26

47.92

1.3

6.34

6.62

mmol/l

0.86

391

1139

Streptococcal septicaemia, including avohilmo

145

385

3.86

47.79

1.3

6.52

6.31

mmol/l

0.31

132

360

malignant neoplasm of female genital organs

135

333

4.02

47.28

1.3

5.52

6.76

mmol/l

6.11

128

307

Diabetic nephropathy, excluding more controls

209

556

3.13

47.24

1.3

9.76

6.73

mmol/l

15.52

195

514

Malignant neoplasm of digestive organs

345

1108

2.40

47.08

1.3

6.27

6.63

mmol/l

1.38

322

1019

Malignant neoplasm of breast, HER2-negative, including Hilmo

257

582

2.85

46.91

1.3

1.2

6.26

6.78

mmol/l

2.59

246

539

Malignant neoplasm of breast, including Hilmo

257

582

2.85

46.90

1.3

1.2

6.26

6.78

mmol/l

2.59

246

539

Malignant neoplasm of breast, HER-positive

213

520

3.08

46.32

1.3

1.2

6.48

6.79

mmol/l

0.94

201

482

Basal cell carcinoma

373

1101

2.33

46.25

1.3

6.08

6.63

mmol/l

3.31

345

1016

Malignant neoplasm of breast, ER-positive, including Hilmo

213

520

3.07

46.21

1.3

1.2

6.48

6.79

mmol/l

0.94

201

482

Malignant neoplasm of skin

399

1204

2.26

46.12

1.4

1.3

6.22

6.62

mmol/l

1.75

374

1106

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

158

296

3.82

46.09

1.4

1.3

6.59

5.41

mmol/l

4.18

144

277

Hypertensive diseases

535

1488

2.04

45.79

1.4

1.3

6.66

5.66

mmol/l

11.31

492

1385

Hypertension

534

1488

2.03

45.46

1.4

1.3

6.67

5.66

mmol/l

11.45

491

1385

Hernia of abdominal wall, postoperative

159

459

3.48

45.43

1.3

6.31

6.25

mmol/l

0.10

149

422

Coronary atherosclerosis

576

1868

1.96

45.28

1.4

1.3

7.05

5.97

mmol/l

14.24

537

1733

Certain infectious and parasitic diseases, including avohilmo

533

1307

2.05

45.08

1.4

1.3

6.31

6.12

mmol/l

0.79

503

1217

Streptococcal septicaemia

140

378

3.80

45.07

1.3

6.50

6.33

mmol/l

0.24

127

353

Gout

373

1440

2.25

44.82

1.4

1.3

6.31

6.42

mmol/l

0.33

354

1331

Insulin medication

564

2448

1.93

44.65

1.4

1.3

9.23

5.57

mmol/l

68.52

525

2289

Other and unspecified iron deficiency

366

1653

2.23

44.52

1.4

1.3

6.76

6.29

mmol/l

2.45

342

1533

Myocardial infarction

478

1639

2.06

43.90

1.4

1.3

7.03

5.97

mmol/l

10.84

441

1523

STROKE

430

1359

2.14

43.80

1.4

1.3

6.78

5.58

mmol/l

11.13

400

1253

Hyperkalaemia

113

269

4.34

43.40

1.3

7.48

6.10

mmol/l

4.41

104

250

Calcific aortic valvular stenosis

394

1785

2.15

43.29

1.4

6.91

6.26

mmol/l

4.91

378

1658

Calcific aortic valvular stenosis, operated

394

1785

2.15

43.29

1.4

6.91

6.26

mmol/l

4.91

378

1658

Secondary hypertension

156

5.47

43.25

1.4

1.2

6.95

5.32

mmol/l

4.42

143

Operations 2 for CAVS

393

1785

2.15

42.90

1.4

6.91

6.26

mmol/l

4.91

378

1658

Calcific aortic valvular stenosis, diagnosis (helper)

393

1785

2.15

42.90

1.4

6.91

6.26

mmol/l

4.91

378

1658

Allergic asthma (mode)

199

4.78

42.72

1.2

1.1

6.12

6.51

mmol/l

0.69

183

Calcific aortic valvular stenosis, including rheumatic fever

393

1789

2.14

42.52

1.4

6.91

6.26

mmol/l

4.96

378

1662

Gout, FINNGEN

373

1747

2.15

41.06

1.4

6.31

6.36

mmol/l

0.12

354

1617

Later onset COPD

387

1474

2.14

40.33

1.4

6.36

6.37

mmol/l

0.02

357

1380

Ulcer of lower limb, not elsewhere classified

211

781

2.76

40.08

1.5

1.4

7.51

6.32

mmol/l

5.20

197

723

Caries of dentine

247

954

2.53

39.47

1.4

1.3

6.52

6.30

mmol/l

0.47

227

886

Depression medications

124

139

4.51

39.35

1.5

1.2

5.93

5.03

mmol/l

2.84

113

126

Other acute lower respiratory infections

491

2460

1.91

39.26

1.3

6.33

6.27

mmol/l

0.15

462

2283

Other disorders of skin and subcutaneous tissue

642

3098

1.76

38.37

1.4

1.3

6.76

6.26

mmol/l

3.46

599

2891

Disorders of lipoprotein metabolism and other lipidaemias

669

2313

1.77

38.15

1.4

1.3

6.85

6.13

mmol/l

6.50

616

2150

Nonischemic cardiomyopathy

140

423

3.38

37.97

1.4

1.3

6.45

6.14

mmol/l

0.74

131

395

Other respiratory diseases principally affecting the interstitium

243

995

2.49

37.54

1.5

1.4

6.63

6.33

mmol/l

0.76

226

919

Cardiodefibrillation

407

2050

2.00

37.22

1.5

1.4

6.51

6.31

mmol/l

0.89

386

1904

Autoimmune diseases excluding thyroid diseases, strict definition

793

2577

1.68

36.99

1.4

1.3

6.59

6.12

mmol/l

3.58

739

2388

Autoimmune diseases excluding thyroid diseases

813

2658

1.66

36.55

1.4

1.3

6.62

6.13

mmol/l

3.84

759

2464

L04AA Selective immunosuppressants

206

790

2.64

36.36

1.6

1.4

6.60

6.24

mmol/l

0.82

195

733

Insulin, combination of fast acting with intermediate-acting or long-acting

565

2894

1.78

35.74

1.4

1.3

9.23

5.83

mmol/l

60.85

525

2698

Insulin, fast-acting

336

1607

2.11

35.58

1.4

1.3

9.83

5.81

mmol/l

51.44

312

1485

Dental caries

263

1071

2.34

35.55

1.4

1.3

6.52

6.33

mmol/l

0.41

243

996

Abnormal findings on examination of blood, without diagnosis

479

2344

1.86

35.03

1.4

6.63

6.27

mmol/l

1.65

444

2182

Hypothyroidism (congenital or acquired)

106

134

4.45

34.87

1.4

1.2

5.91

5.03

mmol/l

3.78

120

Other diseases of blood and blood-forming organs, wide

229

949

2.44

34.41

1.3

1.4

6.14

6.36

mmol/l

0.57

216

878

Oedema, not elsewhere classified

303

1383

2.16

33.99

1.3

1.4

6.68

6.23

mmol/l

1.72

286

1288

Amputation

153

528

2.96

33.25

1.5

1.3

7.73

6.35

mmol/l

4.99

142

491

COPD, hospital admissions 1, only main diagnosis

399

1774

1.95

33.22

1.3

1.4

6.45

6.29

mmol/l

0.51

371

1649

Diabetes mellitus

731

2551

1.66

33.18

1.4

1.3

7.56

5.50

mmol/l

45.47

671

2376

Hypothyroidism, levothyroxine purchases

103

133

4.36

33.16

1.4

1.2

5.89

5.04

mmol/l

3.67

119

Hypothyroidism and >3 levothyroxin purchases

103

133

4.36

33.16

1.4

1.2

5.89

5.04

mmol/l

3.67

119

Insulin, intermediate and long-acting

504

2725

1.80

33.14

1.4

1.3

9.44

5.85

mmol/l

58.77

470

2537

Diabetes, varying definitions

728

2553

1.66

32.96

1.4

1.3

7.56

5.51

mmol/l

44.80

667

2378

Diseases of oesophagus, stomach and duodenum

810

2977

1.61

32.87

1.4

1.3

6.38

6.26

mmol/l

0.53

755

2779

Bronchitis

843

3184

1.59

32.74

1.3

6.29

6.27

mmol/l

0.06

792

2962

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

204

373

2.76

32.73

1.3

1.2

6.40

6.08

mmol/l

0.70

189

341

852

2710

1.60

32.36

1.4

1.3

6.39

6.24

mmol/l

0.68

802

2537

Pure hypercholesterolaemia

607

2245

1.73

32.28

1.4

1.3

6.78

6.14

mmol/l

5.74

565

2087

Type 2 diabetes

716

2516

1.65

31.99

1.4

1.3

7.54

5.51

mmol/l

43.41

656

2342

Myocardial infarction, strict

425

1589

1.91

31.95

1.4

1.3

6.98

5.98

mmol/l

8.82

391

1475

Gout, idiopatic and unspecified

310

1504

2.09

31.88

1.4

6.25

6.27

mmol/l

0.05

293

1388

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

522

2935

1.75

31.78

1.3

6.51

6.30

mmol/l

0.86

489

2734

Diabetic nephropathy

212

876

2.43

31.30

1.3

1.4

9.79

7.19

mmol/l

12.21

198

811

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

187

740

2.57

31.18

1.5

1.4

6.72

6.23

mmol/l

1.27

177

689

Insulin, fast-acting or short human

338

1704

2.00

31.07

1.4

1.3

9.79

5.98

mmol/l

47.42

314

1574

Implicit fungal Sepsis, including avohilmo

270

3.71

30.77

1.5

1.4

7.17

6.14

mmol/l

2.17

254

Intestinal infectious diseases

720

3337

1.61

30.44

1.4

1.3

6.47

6.23

mmol/l

1.37

665

3113

Ischaemic heart disease, wide definition

612

2234

1.69

30.35

1.4

1.3

6.92

6.01

mmol/l

11.35

567

2081

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

687

2490

1.64

30.14

1.4

1.3

8.05

5.51

mmol/l

57.41

634

2322

Diseases of liver

316

1578

2.02

29.93

1.5

1.3

6.68

6.28

mmol/l

1.62

295

1456

Peripheral arterial reconstruction

235

1050

2.28

29.90

1.4

7.70

6.33

mmol/l

7.68

215

968

Fungal Sepsis

170

4.50

29.88

1.5

1.4

7.40

6.04

mmol/l

2.71

162

Antihypertensive medication - note that there are other indications

287

681

2.21

29.79

1.4

1.2

6.42

5.37

mmol/l

8.43

265

623

Endocrine, nutritional and metabolic diseases

494

1378

1.82

29.74

1.4

1.3

6.66

5.40

mmol/l

14.72

460

1283

Other bacterial intestinal infections

195

812

2.43

29.09

1.5

1.4

6.58

6.31

mmol/l

0.59

178

750

Malignant neoplasm of urinary organs, including Hilmo

121

395

3.11

28.98

1.5

1.4

6.06

6.61

mmol/l

1.06

113

359

COPD-related respiratory insufficiency

165

639

2.63

28.84

1.4

6.88

6.40

mmol/l

1.05

149

601

Hypothyroidism, drug reimbursement

5.53

28.73

1.5

1.2

6.31

4.98

mmol/l

3.23

Gout, strict definition

239

1105

2.20

27.99

1.4

6.32

6.29

mmol/l

0.07

225

1018

Enterocolitis due to Clostridium difficile

143

525

2.77

27.77

1.5

1.4

6.51

6.44

mmol/l

0.10

128

493

Peripheral artery operations in Hilmo

170

681

2.54

27.65

1.4

1.3

7.74

6.17

mmol/l

6.45

156

630

Asthma (diagnoses ohter than nonallergic)

663

3363

1.60

27.65

1.4

1.3

6.29

mmol/l

0.01

612

3140

Implicit fungal Sepsis

157

4.48

27.32

1.5

1.4

7.41

6.10

mmol/l

2.36

150

Other bacterial intestinal infections, including avohilmo

226

1032

2.21

27.18

1.4

1.3

6.55

6.29

mmol/l

0.62

206

959

Malignant neoplasm of urinary organs

106

333

3.24

27.13

1.4

1.3

6.10

6.64

mmol/l

0.85

300

489

2563

1.71

27.10

1.3

6.33

6.24

mmol/l

0.27

449

2386

Hyperlipidaemia, other/unspecified

369

1794

1.86

27.09

1.4

1.3

7.03

6.15

mmol/l

4.86

348

1668

Invasive ventilation

100

304

3.37

27.07

1.4

6.67

6.37

mmol/l

0.39

285

Dipeptidyl peptidase 4 (DPP-4) inhibitors

515

2395

1.70

26.93

1.4

1.3

8.29

5.77

mmol/l

38.91

474

2235

Other interstitial pulmonary diseases

197

857

2.34

26.76

1.5

1.4

6.63

6.33

mmol/l

0.64

181

797

ILD, hospital admissions

194

839

2.35

26.72

1.5

1.4

6.61

6.33

mmol/l

0.58

179

780

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

107

342

3.18

26.62

1.5

1.3

6.05

6.62

mmol/l

0.97

102

308

Diabetes, insulin treatment (Kela reimbursement)

750

2875

1.56

26.54

1.4

1.3

8.07

5.61

mmol/l

60.40

694

2682

Interstitial lung disease

197

861

2.33

26.48

1.5

1.4

6.63

6.32

mmol/l

0.68

181

803

Interstitial lung disease endpoints

197

861

2.33

26.48

1.5

1.4

6.63

6.32

mmol/l

0.68

181

803

Coronary artery bypass grafting

289

1067

2.03

26.22

1.4

7.00

6.01

mmol/l

5.50

272

992

Amputation of toe

114

384

3.05

26.07

1.4

7.93

6.37

mmol/l

4.14

105

362

Cough

287

1353

1.99

25.99

1.4

1.3

6.16

6.11

mmol/l

0.10

274

1249

Volume depletion

125

443

2.87

25.96

1.4

1.3

6.71

6.14

mmol/l

1.57

118

409

Persons encountering health services in other circumstances, wide

849

2891

1.51

25.67

1.4

1.3

6.50

6.21

mmol/l

1.84

789

2698

Type 1 diabetes

197

869

2.28

25.66

1.3

9.92

5.48

mmol/l

31.84

184

801

Alcohol use disorder, Swedish definition

465

2487

1.71

25.65

1.4

1.3

6.35

6.23

mmol/l

0.39

426

2317

Persons with potential health hazards related to communicable diseases

223

1026

2.17

25.61

1.3

6.12

mmol/l

0.01

201

953

Substance abuse, excluding more controls

458

2235

1.72

25.60

1.3

1.4

6.17

6.24

mmol/l

0.20

419

2100

Bacterial intestinal infections, IBD co-morbidities

192

842

2.31

25.53

1.5

1.3

6.56

6.38

mmol/l

0.35

175

776

Diarrhoea and gastroenteritis of presumed infectious origin

526

2855

1.65

25.50

1.3

6.43

6.20

mmol/l

1.01

489

2665

Vocal cord dysfunction

105

294

3.17

25.40

1.4

1.3

6.11

5.22

mmol/l

2.59

276

Infections of the skin and subcutaneous tissue

443

2546

1.72

25.39

1.4

1.3

6.49

6.19

mmol/l

1.11

410

2354

Non-Hodgkin lymphoma, all

155

4.31

25.03

1.5

1.3

5.92

6.98

mmol/l

2.27

146

Iron deficiency anaemia secondary to blood loss (chronic)

175

749

2.37

24.66

1.4

6.50

6.31

mmol/l

0.42

163

695

Diseases of the digestive system

425

2459

1.73

24.66

1.4

1.3

6.46

6.32

mmol/l

0.49

402

2291

Pain in limb

623

2494

1.59

24.64

1.3

6.52

6.22

mmol/l

1.71

585

2313

Cerebrovascular diseases

630

2774

1.58

24.57

1.4

1.3

6.88

6.24

mmol/l

5.40

600

2571

Malignant neoplasm of kidney, except renal pelvis

298

3.24

24.42

1.4

1.3

6.16

6.65

mmol/l

0.70

268

Unspecified acute lower respiratory infection

157

645

2.46

24.23

1.3

1.4

6.19

6.34

mmol/l

0.26

144

600

Dilated cardiomyopathy

151

611

2.52

24.19

1.3

1.4

6.87

6.28

mmol/l

1.43

142

571

494

2608

1.66

24.09

1.4

1.3

6.32

6.24

mmol/l

0.26

454

2430

Acute bronchitis

358

1967

1.80

23.84

1.4

6.35

6.31

mmol/l

0.08

342

1824

Disorders resulting from impaired renal tubular function

157

4.22

23.83

1.5

1.4

7.23

6.49

mmol/l

0.92

148

Fall on same level

787

2786

1.51

23.76

1.3

6.36

6.21

mmol/l

0.70

738

2589

Type 2 diabetes, strict (exclude DM1)

669

2506

1.56

23.71

1.3

7.27

5.52

mmol/l

33.39

613

2332

Type 2 diabetes, definitions combined

664

2486

1.56

23.58

1.3

7.24

5.51

mmol/l

32.82

609

2315

Asthma/COPD (KELA code 203)

660

2853

1.55

23.52

1.4

1.3

6.36

6.26

mmol/l

0.37

616

2663

GI-bleeding

332

1837

1.82

23.19

1.5

1.4

6.55

6.27

mmol/l

1.00

312

1708

Gout, unspecified

243

1217

2.02

23.10

1.4

6.41

6.31

mmol/l

0.29

230

1121

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

467

2838

1.65

22.97

1.3

6.54

6.30

mmol/l

0.98

437

2647

Squamous cell neoplasms and carcinomas of the skin

114

412

2.81

22.84

1.4

6.66

6.75

mmol/l

0.11

109

377

Substance abuse

458

2581

1.66

22.66

1.3

6.17

6.27

mmol/l

0.28

419

2405

Exposure to unspecified factor

734

3335

1.50

22.63

1.3

6.34

6.27

mmol/l

0.28

688

3104

Other soft tissue disorders, not elsewhere classified

677

2523

1.53

22.12

1.3

6.38

6.21

mmol/l

0.73

635

2338

Used for control exclusion in common control thyroid runs

737

2470

1.51

21.95

1.4

1.3

6.47

6.10

mmol/l

2.65

683

2288

Disorders of gallbladder, biliary tract and pancreas

740

3093

1.49

21.91

1.4

1.3

6.69

6.19

mmol/l

4.17

705

2870

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

131

513

2.56

21.89

1.3

1.4

6.90

6.66

mmol/l

0.28

126

472

Abnormalities of heart beat

250

1245

1.96

21.85

1.4

1.3

6.68

6.13

mmol/l

2.79

234

1148

Asthma and allergy, excluding more controls

5.26

21.85

1.2

1.1

5.37

6.31

mmol/l

1.45

Use of hypnotics and sedatives

768

2962

1.49

21.85

1.3

6.36

6.25

mmol/l

0.49

705

2767

Hypokalaemia

125

485

2.61

21.82

1.3

6.21

6.19

mmol/l

0.04

120

448

Mental and behavioural disorders due to psychoactive substance use

466

2625

1.63

21.81

1.3

6.19

6.27

mmol/l

0.22

427

2446

Type 1 diabetes, wide definition, subgroup 1

153

651

2.37

21.78

1.3

10.55

5.43

mmol/l

33.95

141

602

Syncope and collapse

359

1714

1.76

21.73

1.4

1.3

6.63

6.23

mmol/l

1.98

336

1595

Other diseases of the digestive system

326

1831

1.80

21.72

1.5

1.3

6.54

6.26

mmol/l

0.98

307

1704

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

724

3070

1.50

21.63

1.4

1.3

6.25

6.30

mmol/l

0.17

677

2855

Codeine or tramadol medication

801

2963

1.47

21.54

1.3

6.38

6.23

mmol/l

0.80

747

2758

Stroke, including SAH

555

2539

1.58

21.53

1.4

1.3

6.86

6.25

mmol/l

4.35

525

2351

ILD, hospital admissions 1, main diag only

167

752

2.26

21.04

1.4

6.64

6.35

mmol/l

0.55

152

701

Factors influencing health status and contact with health services

214

500

2.16

20.95

1.4

1.2

6.37

5.96

mmol/l

1.27

200

460

Emphysema

100

355

2.87

20.84

1.4

6.10

6.37

mmol/l

0.34

332

Misadventures to patients during surgical and medical care

142

601

2.39

20.62

1.5

1.4

6.60

6.27

mmol/l

0.74

134

558

Mental and behavioural disorders due to alcohol, excluding acute intoxication

364

2124

1.71

20.49

1.3

1.4

6.16

6.23

mmol/l

0.18

332

1973

Type 2 diabetes, definitions combined, including avohilmo

650

2486

1.52

20.44

1.3

7.19

5.51

mmol/l

30.94

597

2311

Disorders of lens

519

2032

1.59

20.42

1.4

1.3

6.79

6.12

mmol/l

5.15

484

1878

Autoimmune diseases

771

2667

1.47

20.40

1.4

1.3

6.46

6.13

mmol/l

2.22

720

2473

Persons encountering health services for specific procedures, not carried out

233

3.30

20.32

1.3

5.56

6.16

mmol/l

0.95

218

108

405

2.69

20.17

1.4

1.3

6.34

6.22

mmol/l

0.15

379

Osteopathies and chondropathies

430

2427

1.63

19.85

1.4

1.3

6.52

6.32

mmol/l

0.77

395

2260

Pain, not elsewhere classified

201

993

2.04

19.80

1.3

6.42

6.23

mmol/l

0.40

183

920

311

1756

1.77

19.75

1.3

6.21

6.25

mmol/l

0.10

291

1626

Idiopathic gout

130

541

2.45

19.73

1.5

1.4

5.99

6.31

mmol/l

0.72

121

500

Injuries to the head

782

3212

1.45

19.72

1.3

6.37

6.24

mmol/l

0.52

729

2994

Diabetes medication

712

2827

1.48

19.68

1.4

1.3

7.80

5.58

mmol/l

48.74

651

2642

Benign neoplasm of colon, rectum, anus and anal canal

542

2985

1.54

19.68

1.4

1.3

6.76

6.28

mmol/l

3.12

501

2789

Stroke, excluding SAH

530

2472

1.56

19.46

1.4

6.88

6.25

mmol/l

4.31

499

2299

Hydronephrosis

115

455

2.56

19.35

1.3

1.4

5.88

6.01

mmol/l

0.22

109

424

Persons encountering health services for other counselling and medical advice, not elsewhere classified

778

2861

1.45

19.25

1.4

1.3

6.59

6.20

mmol/l

2.50

727

2670

Type 1 diabetes, wide definition

160

732

2.20

19.24

1.3

10.40

5.48

mmol/l

33.71

148

678

Non-follicular lymphoma

119

481

2.52

19.22

1.5

1.4

6.06

6.37

mmol/l

0.64

113

452

Coagulation defects, purpura and other haemorrhagic conditions

176

838

2.12

19.22

1.4

6.16

6.33

mmol/l

0.30

165

782

Agranulocytosis

113

445

2.58

19.22

1.3

1.4

5.88

6.31

mmol/l

0.87

107

422

Other diseases of intestines

707

2683

1.47

19.17

1.3

6.26

6.25

mmol/l

0.02

653

2493

Early onset COPD

198

987

2.03

19.12

1.3

1.4

6.62

6.30

mmol/l

0.67

184

912

Pneumonia derived septicemia

138

4.03

19.06

1.4

5.93

6.27

mmol/l

0.40

132

Angina pectoris

430

1759

1.63

18.95

1.4

1.3

6.94

6.00

mmol/l

8.14

396

1634

Myocardial infarction, without ST-elevation

410

2290

1.63

18.84

1.4

7.10

6.26

mmol/l

6.48

384

2134

L02BG Aromatase inhibitors

203

1015

1.99

18.68

1.3

6.43

6.46

mmol/l

0.06

193

953

Gastroduodenal ulcer

268

1483

1.82

18.67

1.4

1.3

6.59

6.31

mmol/l

0.85

251

1385

Symptoms and signs involving the urinary system

585

2943

1.50

18.67

1.4

1.3

6.38

6.33

mmol/l

0.17

539

2744

Mental and behavioural disorders due to alcohol

402

2369

1.62

18.59

1.3

6.18

6.23

mmol/l

0.10

369

2207

Intestinal stricture

286

1622

1.78

18.53

1.3

1.4

6.17

6.36

mmol/l

0.56

264

1506

Intestinal infectious diseases, including avohilmo, including avohilmo

819

3216

1.42

18.53

1.3

6.53

6.22

mmol/l

2.12

759

3004

Medicines for HER+ breast cancer

234

1159

1.89

18.42

1.3

6.37

6.46

mmol/l

0.22

222

1093

Colorectal cancer, including Hilmo

196

915

2.01

18.41

1.3

1.4

6.42

6.60

mmol/l

0.37

184

841

Reimbursement for rheumatic diseases

402

2483

1.62

18.36

1.4

1.3

5.86

6.36

mmol/l

3.08

369

2307

L02BA Anti-estrogens

119

491

2.45

18.30

1.3

6.20

6.45

mmol/l

0.56

113

457

Need for other prophylactic measures

219

3.26

18.23

1.5

1.4

6.06

6.38

mmol/l

0.44

206

L04AX Other immunosuppressants

382

2354

1.63

18.05

1.4

1.3

5.78

6.34

mmol/l

3.44

352

2197

Alcohol use disorder, ICD-based

332

1978

1.69

18.00

1.3

6.22

6.24

mmol/l

0.04

300

1836

Myocarditis

4.73

17.99

1.4

1.1

6.59

5.61

mmol/l

1.03

Other CVD

223

1184

1.90

17.96

1.4

6.59

6.39

mmol/l

0.44

213

1092

Abnormal findings on diagnostic imaging of other body structures

124

528

2.37

17.82

1.5

1.3

6.90

6.46

mmol/l

1.01

118

495

Second line medication for Crohn's disease

388

2408

1.62

17.78

1.4

1.3

5.78

6.34

mmol/l

3.56

357

2243

Symptoms and signs involving the digestive system and abdomen

698

2405

1.46

17.72

1.4

1.3

6.32

6.26

mmol/l

0.18

645

2249

Ischaemic Stroke, excluding all haemorrhages

506

2437

1.54

17.69

1.4

6.95

6.22

mmol/l

5.50

479

2270

Alcoholic liver disease

112

461

2.47

17.42

1.4

6.58

6.15

mmol/l

0.64

104

425

Acute peritonitis

284

2.91

17.36

1.4

7.09

6.30

mmol/l

1.12

270

All influenza (not pneumonia)

346

2.68

17.14

1.4

1.3

6.45

6.14

mmol/l

0.39

327

Paralytic ileus and intestinal obstruction

244

1352

1.82

17.10

1.3

1.4

6.07

6.36

mmol/l

0.89

226

1251

Purpura and other haemorrhagic conditions

133

596

2.26

17.01

1.4

6.06

6.41

mmol/l

0.61

125

559

Asthma and allergy

103

4.23

16.95

1.2

1.1

5.37

6.41

mmol/l

1.83

Malignant neoplasm of head and neck, including Hilmo

326

2.73

16.94

1.4

1.3

5.95

6.59

mmol/l

1.28

297

Retention of urine

343

1685

1.66

16.75

1.4

6.57

6.27

mmol/l

1.13

317

1566

Colorectal cancer

176

848

2.00

16.55

1.3

1.4

6.36

6.56

mmol/l

0.39

165

781

Pneumococcal septicemia

139

3.77

16.50

1.4

6.00

6.21

mmol/l

0.22

133

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

380

2.57

16.28

1.5

1.4

6.87

6.46

mmol/l

0.55

363

Other disorders of kidney and ureter

136

630

2.19

16.09

1.5

1.4

6.64

6.37

mmol/l

0.46

126

589

Senile cataract

485

1940

1.53

16.01

1.4

1.3

6.80

6.10

mmol/l

5.31

455

1793

Disorders of choroid and retina

622

3029

1.44

15.94

1.4

1.3

7.14

6.18

mmol/l

10.69

593

2814

Diabetic retinopathy, excluding more controls

214

633

1.91

15.57

1.3

8.89

6.71

mmol/l

13.93

204

586

Rheumatoid arthritis

268

1385

1.72

15.47

1.4

1.3

5.84

6.40

mmol/l

2.25

248

1288

Malignant neoplasm of head and neck

274

2.81

15.45

1.4

1.3

6.00

6.55

mmol/l

0.95

247

Asthma, hospital admissions , main diagnosis only

555

3332

1.45

15.34

1.3

6.28

6.27

mmol/l

0.01

513

3107

Fentanyl

106

452

2.37

15.20

1.5

1.4

5.86

6.47

mmol/l

1.42

414

Injuries to the hip and thigh

414

2424

1.54

15.17

1.3

1.4

6.43

6.32

mmol/l

0.32

396

2257

Fracture of femur

275

1468

1.70

15.13

1.2

1.4

6.59

6.41

mmol/l

0.43

261

1365

Intracranial trauma

381

1633

1.58

15.07

1.3

6.27

6.06

mmol/l

0.78

355

1518

Sequelae of external causes of morbidity and mortality

216

1205

1.81

14.93

1.4

1.3

6.77

6.31

mmol/l

1.35

203

1116

Other cataract

361

1695

1.59

14.87

1.4

7.09

6.13

mmol/l

5.58

343

1571

Malnutrition

4.48

14.62

1.5

1.3

5.71

6.43

mmol/l

0.73

Other disorders of glucose regulation and pancreatic internal secretion

323

2.60

14.58

1.4

9.45

6.39

mmol/l

5.45

305

Rheumatoid arthritis, including avohilmo

285

1730

1.66

14.51

1.4

1.3

5.86

6.36

mmol/l

2.01

264

1603

Diagnoses used for exclusion with ILD

228

1306

1.76

14.42

1.5

1.4

6.65

6.34

mmol/l

0.89

216

1200

Constipation

649

3140

1.40

14.34

1.3

6.29

6.32

mmol/l

0.10

602

2929

Cellulitis

180

964

1.88

14.21

1.4

1.3

6.50

6.25

mmol/l

0.52

163

896

Other retinal disorders

524

2751

1.45

14.20

1.4

7.39

6.20

mmol/l

12.74

504

2557

Disorders of thyroid, IBD co-morbidities

119

365

2.24

14.07

1.5

1.2

6.48

5.43

mmol/l

4.66

104

341

Drug-induced neutropenia

278

2.71

13.99

1.3

1.4

5.73

6.32

mmol/l

1.04

261

Diseases of the skin and subcutaneous tissue

655

2338

1.41

13.98

1.4

1.3

6.37

6.19

mmol/l

0.77

603

2171

Use of anticholinesterases

134

2028

0.51

13.96

1.2

1.4

6.23

6.41

mmol/l

0.31

119

1904

N06DA Anticholinesterases

134

2028

0.51

13.96

1.2

1.4

6.23

6.41

mmol/l

0.31

119

1904

Injuries to the abdomen, lower back, lumbar spine and pelvis

320

1990

1.59

13.90

1.4

1.3

6.09

6.37

mmol/l

0.95

301

1847

Viral hepatitis, IBD co-morbidity

108

3.84

13.86

1.2

5.59

5.65

mmol/l

0.04

100

Nausea and vomiting

208

1143

1.78

13.85

1.4

1.3

6.50

6.37

mmol/l

0.27

193

1055

Other or unspecified ileus, impaction or obstruction

176

944

1.88

13.85

1.3

1.4

6.06

6.39

mmol/l

0.81

161

869

Benign neoplasm: Colon

450

2868

1.48

13.80

1.4

1.3

6.84

6.27

mmol/l

3.29

412

2682

Convulsions, not elsewhere classified

158

808

1.94

13.77

1.3

1.4

6.48

6.12

mmol/l

0.70

145

738

Amiodarone users

116

539

2.19

13.73

1.3

1.4

6.80

6.34

mmol/l

1.01

109

506

Falls/tendency to fall

675

2426

1.40

13.72

1.4

1.3

6.40

6.21

mmol/l

0.89

627

2247

Unstable angina pectoris

311

1525

1.61

13.67

1.4

1.3

7.00

6.05

mmol/l

5.76

290

1422

Other (not insulin) diabetes medications

658

2776

1.39

13.66

1.3

7.68

5.59

mmol/l

40.75

602

2594

Other symptoms and signs involving the circulatory and respiratory systems

199

3.00

13.58

1.4

1.3

5.70

6.28

mmol/l

0.80

184

Other arthritis (FG)

234

1374

1.71

13.55

1.4

1.3

5.94

6.35

mmol/l

1.55

221

1280

Unspecified haematuria

372

1979

1.54

13.49

1.4

6.28

6.30

mmol/l

0.06

348

1838

Chronic pancreatitis

119

562

2.14

13.48

1.4

7.32

6.24

mmol/l

2.14

112

519

In situ neoplasms

322

2052

1.58

13.47

1.3

6.42

6.29

mmol/l

0.28

305

1905

Osteoporosis

224

1196

1.73

13.32

1.4

6.42

6.41

mmol/l

0.02

210

1125

Asthma, including avohilmo

791

3240

1.35

13.13

1.3

6.20

6.28

mmol/l

0.35

734

3022

Presence of other functional implants

459

2145

1.47

13.09

1.4

1.3

6.69

6.19

mmol/l

3.14

435

1988

Thrombocytopenia, unspecified

324

2.51

13.02

1.5

1.4

5.99

6.48

mmol/l

0.89

306

Unspecified fall

384

2515

1.50

12.96

1.3

6.37

6.27

mmol/l

0.27

362

2341

Hypotension

186

1038

1.81

12.95

1.5

1.4

6.51

6.37

mmol/l

0.24

176

957

Biguanides

654

2868

1.38

12.87

1.3

7.70

5.77

mmol/l

34.64

598

2679

Fracture of rib(s), sternum and thoracic spine

266

1639

1.63

12.86

1.3

1.4

6.07

6.34

mmol/l

0.82

253

1511

Seropositive rheumatoid arthritis

200

1136

1.76

12.82

1.4

1.3

5.86

6.43

mmol/l

1.65

180

1054

Mycoses

214

1247

1.73

12.79

1.4

1.3

6.72

6.30

mmol/l

1.06

197

1151

Malignant neoplasm of colon, including Hilmo

135

678

2.00

12.77

1.3

1.4

6.33

6.57

mmol/l

0.43

127

622

Genitourinary diseases

371

1205

1.55

12.74

1.4

1.3

6.41

5.79

mmol/l

3.69

347

1113

Hernia

625

3014

1.38

12.59

1.3

6.25

6.34

mmol/l

0.36

583

2810

Other specified/unspecified arthritis

210

1225

1.72

12.51

1.3

5.97

6.32

mmol/l

1.11

198

1147

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

196

1125

1.75

12.39

1.4

1.3

5.86

6.41

mmol/l

1.53

176

1051

Sulfasalazine

186

1054

1.77

12.27

1.4

1.3

5.59

6.35

mmol/l

3.01

170

978

Injuries to the thorax

366

2449

1.50

12.23

1.4

1.3

6.16

6.31

mmol/l

0.42

349

2270

Problems related to lifestyle

334

2.42

12.17

1.3

6.58

6.09

mmol/l

0.68

311

Benzodiazepine use

679

3392

1.35

12.13

1.3

6.12

6.31

mmol/l

0.97

618

3180

Polyneuropathies and other disorders of the peripheral nervous system

198

1150

1.74

12.04

1.3

1.4

6.76

6.26

mmol/l

1.38

185

1056

Diverticular disease of intestine

533

2359

1.41

12.04

1.4

1.3

6.33

6.34

mmol/l

0.03

497

2197

Seropositive rheumatoid arthritis, wide

200

1166

1.73

11.98

1.4

1.3

5.86

6.40

mmol/l

1.54

180

1089

Fracture of lumbar spine and pelvis

202

1180

1.72

11.91

1.5

1.4

6.27

6.40

mmol/l

0.23

192

1098

Lung diseases due to external agents

146

777

1.90

11.89

1.3

1.4

6.49

6.37

mmol/l

0.20

137

722

Aortic aneurysm

229

1362

1.66

11.81

1.4

5.99

6.07

mmol/l

0.19

212

1273

Other/unspecified seropositive rheumatoid arthritis

197

1150

1.72

11.75

1.4

1.3

5.87

6.42

mmol/l

1.54

177

1074

Diseases of peritoneum

441

2.20

11.73

1.4

1.5

7.01

6.22

mmol/l

1.41

414

Autoimmune diseases related-to ILD

551

3335

1.38

11.64

1.4

1.3

6.27

mmol/l

0.00

514

3109

Dysphagia

206

1228

1.69

11.39

1.4

1.3

6.28

6.27

mmol/l

0.01

196

1136

Carcinoma in situ of skin of other and unspecified parts of face

105

509

2.09

11.24

1.3

1.4

6.62

6.39

mmol/l

0.20

479

Sequelae with surgical and medical care as external cause

168

951

1.78

11.21

1.4

6.81

6.33

mmol/l

1.30

159

881

Malignant neoplasm of colon

114

569

2.02

11.19

1.3

1.4

6.23

6.56

mmol/l

0.56

107

521

Certain disorders involving the immune mechanism

140

750

1.88

11.17

1.6

1.3

6.97

6.24

mmol/l

2.23

134

696

Unspecified misadventure during surgical and medical care

240

2.63

11.15

1.4

6.38

6.47

mmol/l

0.11

227

Other external causes of accidental injury

517

1844

1.41

11.13

1.4

1.3

6.43

6.18

mmol/l

1.11

485

1707

Persons encountering health services in other circumstances

269

1707

1.57

11.01

1.3

6.38

6.15

mmol/l

0.67

254

1588

Hypoglycaemia, other or unspecified

261

2.52

10.83

1.4

9.29

6.25

mmol/l

4.14

246

Benign neoplasms

629

2538

1.35

10.77

1.4

1.3

6.35

6.15

mmol/l

0.94

589

2360

Other antidepressants

702

2698

1.33

10.72

1.3

6.39

6.24

mmol/l

0.63

648

2529

Accidents

513

1844

1.40

10.60

1.4

1.3

6.50

6.18

mmol/l

1.58

483

1707

Sub-endpoint used in defining T1D endpoints

209

1261

1.64

10.36

1.3

9.96

6.07

mmol/l

28.63

195

1168

Chronic nephritic syndrome

153

3.00

10.36

1.7

1.3

6.98

6.37

mmol/l

0.49

145

Seropositive rheumatoid arthritis, strict definition

115

593

1.96

10.34

1.4

5.70

6.33

mmol/l

1.12

559

Osteomyelitis

304

2.37

10.33

1.5

1.4

8.21

6.37

mmol/l

3.86

286

Gastrointestinal diseases

314

1032

1.53

10.31

1.4

1.3

6.23

6.04

mmol/l

0.60

295

957

Open wound of head

404

2678

1.42

10.24

1.3

1.4

6.43

6.26

mmol/l

0.55

377

2491

Cutaneous abscess, furuncle and carbuncle

177

1045

1.70

10.20

1.5

1.3

6.62

6.24

mmol/l

0.74

166

970

Obesity related asthma

228

1438

1.59

10.12

1.3

6.58

6.29

mmol/l

0.75

200

1337

Substance use, excluding alcohol

121

642

1.90

9.99

1.2

1.4

6.03

6.15

mmol/l

0.16

110

600

Open wound of lower leg

116

609

1.92

9.91

1.5

1.4

6.97

6.32

mmol/l

0.97

107

567

Symptoms and signs concerning food and fluid intake

431

2.10

9.90

1.3

1.4

6.16

6.28

mmol/l

0.13

402

Cholelithiasis, broad definition with cholecystitis

594

2963

1.34

9.88

1.3

6.61

6.20

mmol/l

2.75

565

2751

Dermatitis

428

3008

1.40

9.85

1.4

1.3

6.39

6.32

mmol/l

0.20

393

2801

Contact with and exposure to communicable diseases

132

722

1.83

9.73

1.3

5.89

6.00

mmol/l

0.26

122

671

Concussion

311

1628

1.48

9.71

1.3

6.13

6.06

mmol/l

0.17

290

1513

Colorectal adenocarcinoma

139

767

1.80

9.71

1.2

1.4

6.48

6.56

mmol/l

0.11

132

705

Other gastritis (incl. Duodenitis)

176

1059

1.67

9.50

1.4

1.3

6.47

6.30

mmol/l

0.32

161

973

Hodgkin lymphoma, hilmo

103

3.37

9.50

1.4

1.3

6.61

6.23

mmol/l

0.55

Other viral diseases

164

964

1.70

9.49

1.3

6.58

6.20

mmol/l

0.75

147

902

Other complications of surgical and medical care, not elsewhere classified

354

2.20

9.47

1.4

6.31

6.32

mmol/l

0.01

334

ILD-related respiratory insufficiency

179

2.75

9.39

1.3

1.4

6.95

6.47

mmol/l

0.38

173

Duodenal ulcer

113

600

1.90

9.39

1.4

1.3

6.72

6.36

mmol/l

0.62

106

558

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

658

3231

1.31

9.37

1.3

6.41

6.22

mmol/l

0.87

607

3017

Viral infections characterized by skin and mucous membrane lesions

274

1831

1.50

9.35

1.4

1.3

6.30

6.31

mmol/l

0.02

256

1693

Acute pancreatitis

157

924

1.71

9.23

1.4

1.3

7.09

6.24

mmol/l

2.18

146

848

Other and unspecified polyneuropathies, also in other diseases

169

1016

1.68

9.19

1.3

1.4

6.76

6.26

mmol/l

1.23

159

934

Other viral diseases, including avohilmo

196

1209

1.61

9.17

1.3

6.50

6.15

mmol/l

0.84

177

1121

Malignant neoplasm of oral cavity, including Hilmo

137

2.96

9.10

1.4

1.3

6.05

6.62

mmol/l

0.55

126

Malignant neoplasm of bladder, including Hilmo

101

517

1.94

8.98

1.4

6.89

6.62

mmol/l

0.43

475

Intracranial injury

403

2716

1.39

8.92

1.3

6.41

6.26

mmol/l

0.50

376

2534

Finngen Rheumatological endpoints

584

2508

1.32

8.90

1.4

1.3

6.19

6.30

mmol/l

0.41

537

2328

Disorders of other endocrine glands

273

1816

1.48

8.85

1.3

6.65

6.32

mmol/l

1.02

253

1685

Congenital malformations, deformations and chromosomal abnormalities

307

2010

1.45

8.83

1.4

1.3

6.19

6.22

mmol/l

0.06

292

1858

Thyrotoxicosis

159

951

1.68

8.80

1.5

1.3

6.93

6.33

mmol/l

2.26

145

888

Gastric ulcer

159

952

1.68

8.80

1.4

1.3

6.49

6.35

mmol/l

0.31

149

879

Symptoms and signs involving cognition, perception, emotional state and behaviour

627

3229

1.30

8.62

1.3

6.56

6.23

mmol/l

2.23

573

3020

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

304

2.23

8.57

1.6

1.4

6.85

6.41

mmol/l

0.54

287

Pain (limb, back, neck, head abdominally)

484

1790

1.36

8.55

1.4

1.3

6.42

6.13

mmol/l

1.33

453

1664

Other infectious diseases, including avohilmo

411

2.04

8.48

1.6

1.4

6.29

6.42

mmol/l

0.14

386

Other disorders of white blood cells

231

2.42

8.43

1.5

6.21

6.46

mmol/l

0.26

216

Poisoning by drugs, medicaments and biological substances

124

706

1.76

8.23

1.2

1.3

6.28

6.07

mmol/l

0.34

107

664

Other neurological diseases

521

3075

1.32

8.09

1.4

1.3

6.64

6.30

mmol/l

2.18

495

2855

Thyrotoxicosis, other and/or unspecified

125

718

1.75

8.07

1.5

1.4

6.99

6.31

mmol/l

2.34

114

667

Soft tissue disorders

639

2539

1.29

8.02

1.4

1.3

6.39

6.21

mmol/l

0.88

590

2353

Chronic apical periodontitis

707

3122

1.27

8.01

1.3

6.29

6.28

mmol/l

0.01

659

2908

Unspecific neurodegenerative disorder

208

2149

0.66

7.97

1.2

1.4

6.22

6.39

mmol/l

0.40

188

2022

External causes of morbidity and mortality

384

1386

1.39

7.92

1.5

1.3

6.25

6.16

mmol/l

0.23

366

1279

Other functional intestinal disorders

320

2066

1.41

7.91

1.4

1.3

6.35

6.32

mmol/l

0.07

293

1926

Actinic keratosis

337

2204

1.40

7.83

1.4

6.38

6.37

mmol/l

0.02

317

2056

Examination and observation for other reasons

385

1575

1.38

7.82

1.4

1.3

6.25

6.06

mmol/l

0.58

358

1471

Acute pancreatitis (for exclusion)

157

968

1.63

7.80

1.4

7.09

6.27

mmol/l

2.05

146

902

Other and unspecified dermatitis

343

2480

1.39

7.77

1.4

1.3

6.36

6.32

mmol/l

0.08

315

2309

354

2311

1.38

7.76

1.4

6.41

6.36

mmol/l

0.10

330

2157

Status post-ami

217

1085

1.53

7.74

1.3

1.4

6.72

6.01

mmol/l

3.28

204

1008

Chronic viral hepatitis

117

2.94

7.70

1.3

1.2

5.02

6.26

mmol/l

1.54

108

Other symptoms and signs involving the urinary system

489

1.90

7.70

1.5

1.3

6.32

6.34

mmol/l

0.02

454

Alzheimer disease, including avohilmo

182

1938

0.65

7.69

1.3

1.4

6.31

6.39

mmol/l

0.15

163

1823

Candidiasis

539

1.85

7.67

1.4

6.81

6.22

mmol/l

1.06

506

Phlebitis and thrombophlebitis (not including DVT)

158

981

1.62

7.64

1.3

1.4

6.00

6.32

mmol/l

0.68

149

906

Cholelithiasis

554

2921

1.30

7.59

1.3

6.64

6.20

mmol/l

2.93

526

2712

Use of donepezil

1382

0.52

7.59

1.2

1.4

6.03

6.41

mmol/l

0.61

1296

Injury, poisoning and certain other consequences of external causes

318

1122

1.42

7.51

1.5

1.3

6.27

6.16

mmol/l

0.28

306

1038

Paracetamol or NSAID medication

110

301

1.85

7.48

1.3

1.4

6.23

6.51

mmol/l

0.44

105

288

Malignant melanoma, including Hilmo

106

595

1.79

7.44

1.4

6.18

6.59

mmol/l

0.67

100

545

Abdominal and pelvic pain

614

2405

1.28

7.41

1.4

1.3

6.43

6.26

mmol/l

0.72

571

2249

Skin changes due to chronic exposure to nonionizing radiation

339

2232

1.38

7.37

1.4

6.39

6.37

mmol/l

0.03

318

2084

DVT of lower extremities

149

921

1.63

7.36

1.3

1.4

6.28

6.31

mmol/l

0.03

138

848

malignant neoplasm of male genital organs

199

777

1.55

7.35

1.4

6.09

6.50

mmol/l

1.20

173

714

Candidiasis, including avohilmo

179

1155

1.56

7.35

1.4

1.3

6.44

6.34

mmol/l

0.17

166

1073

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

337

2231

1.38

7.32

1.4

1.3

6.12

6.21

mmol/l

0.27

320

2062

Diabetic retinopathy

279

1208

1.44

7.27

1.3

1.4

8.78

7.32

mmol/l

8.71

267

1120

Delirium, not induced by alcohol and other psychoactive substances

129

770

1.69

7.27

1.3

1.4

6.72

6.40

mmol/l

0.67

115

717

Malignant melanoma

520

1.84

7.26

1.5

1.4

6.35

6.56

mmol/l

0.25

474

Other (seronegative) rheumatoid arthritis, wide

135

817

1.66

7.26

1.3

1.4

5.68

6.43

mmol/l

2.23

130

762

malignant neoplasm of male genital organs, including Hilmo

200

785

1.54

7.14

1.4

6.01

6.49

mmol/l

1.58

174

722

Other and unspecified local infections of skin and subcutaneous tissue

377

1.98

7.05

1.5

1.4

6.55

6.30

mmol/l

0.26

352

Other symptoms and signs involving the digestive system and abdomen

107

613

1.75

7.03

1.3

6.14

6.39

mmol/l

0.37

101

572

Systemic connective tissue disorders

233

1608

1.45

6.95

1.4

1.3

6.43

6.31

mmol/l

0.27

214

1497

Other diseases of intestine

122

729

1.68

6.91

1.3

1.4

6.55

6.34

mmol/l

0.31

114

673

Tuberculosis

319

2.06

6.90

1.5

1.4

5.96

6.49

mmol/l

0.76

304

Dentofacial anomalies [including malocclusion]

182

2135

0.67

6.87

1.3

5.86

6.25

mmol/l

1.82

172

1982

Other diseases of arteries and capillaries

367

1.98

6.87

1.3

7.31

6.30

mmol/l

1.62

344

Other noninfective gastroenteritis and colitis

158

1009

1.57

6.81

1.3

1.4

6.66

6.31

mmol/l

0.77

143

941

Other local infections of skin and subcutaneous tissue

410

1.92

6.80

1.4

6.48

6.28

mmol/l

0.21

383

Chronic gastritis

208

1411

1.48

6.80

1.4

1.3

6.40

6.33

mmol/l

0.14

202

1314

Malignant neoplasm, without specification of site

115

2.82

6.77

1.1

1.3

7.41

7.04

mmol/l

0.17

109

Other special examinations and investigations of persons without complaint or reported diagnosis

421

1602

1.33

6.76

1.4

1.3

6.50

6.06

mmol/l

2.33

397

1494

Personality disorders, excluding more controls

116

686

1.69

6.75

1.2

1.3

6.58

6.09

mmol/l

0.82

102

645

Other skin changes

153

974

1.58

6.73

1.4

6.70

6.34

mmol/l

0.91

145

904

Chronic periodontitis, complicated

377

2762

1.33

6.70

1.3

6.32

6.30

mmol/l

0.04

346

2577

Arterial embolism and thrombosis

269

2.14

6.70

1.3

7.42

6.36

mmol/l

1.31

252

Other viral hepatitis

150

2.55

6.69

1.3

5.21

6.36

mmol/l

1.63

140

Other viral hepatitis, including avohilmo

158

2.49

6.51

1.3

5.25

6.32

mmol/l

1.52

148

Alcohol dependence

188

1262

1.50

6.50

1.3

1.4

6.35

6.25

mmol/l

0.16

169

1165

Transient ischemic attack

399

2412

1.32

6.49

1.4

6.67

6.25

mmol/l

2.35

378

2247

Low back pain

486

2547

1.29

6.49

1.3

6.40

6.20

mmol/l

0.79

447

2373

Malignant melanoma of skin, including Hilmo

474

1.82

6.48

1.5

1.4

6.32

6.54

mmol/l

0.24

429

Fracture of lower leg, including ankle

340

2485

1.35

6.47

1.3

6.67

6.29

mmol/l

1.47

313

2308

Neurological diseases, wide definition

135

409

1.66

6.46

1.3

1.2

6.21

5.37

mmol/l

3.70

126

380

Tuberculosis, IBD comorbidity

355

1.96

6.45

1.5

1.4

5.74

6.55

mmol/l

1.53

338

Use of other anti-dementia drugs

132

1675

0.63

6.43

1.2

1.4

6.50

6.40

mmol/l

0.17

112

1583

Use of memantine

132

1675

0.63

6.43

1.2

1.4

6.50

6.40

mmol/l

0.17

112

1583

Covid-19 suspected case

109

646

1.69

6.38

1.5

1.3

6.47

6.15

mmol/l

0.55

101

604

Abnormal results of function studies

288

2.06

6.36

1.5

1.4

6.45

6.31

mmol/l

0.17

272

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

427

1.87

6.36

1.5

1.4

6.31

6.39

mmol/l

0.09

395

Viral hepatitis, including avohilmo

204

2.27

6.30

1.3

5.71

6.31

mmol/l

0.54

189

Respiratory tuberculosis

277

2.08

6.26

1.5

1.4

5.78

6.44

mmol/l

0.96

263

Respiratory tuberculosis, confirmed and not-confirmed

277

2.08

6.26

1.5

1.4

5.78

6.44

mmol/l

0.96

263

Other disorders of skin and subcutaneous tissue, not elsewhere classified

108

643

1.69

6.25

1.4

7.40

6.29

mmol/l

2.48

102

600

Viral hepatitis

199

2.28

6.21

1.3

5.69

6.34

mmol/l

0.58

185

Vascular disorders of the intestines

360

1.94

6.20

1.5

1.4

6.57

6.44

mmol/l

0.14

339

Thoracic aortic aneurysm

120

738

1.64

6.15

1.4

1.3

5.73

6.14

mmol/l

1.29

112

688

Other other unspecified disorders of the circulatory system

157

2.46

6.14

1.3

6.96

6.52

mmol/l

0.46

149

Chronic periodontitis, including avohilmo

626

3217

1.24

6.11

1.3

6.14

6.32

mmol/l

0.92

581

3004

Dementia in Alzheimer disease

1123

0.55

6.11

1.2

1.4

6.40

6.42

mmol/l

0.02

1066

Poisoning by medicine

105

625

1.69

6.07

1.2

1.4

6.34

6.12

mmol/l

0.31

588

Acute upper respiratory infections of multiple and unspecified sites

456

2592

1.29

6.02

1.4

1.3

6.40

6.20

mmol/l

0.74

425

2412

Diseases of the eye and adnexa

424

1628

1.31

5.97

1.4

1.3

6.22

5.95

mmol/l

1.15

396

1508

Periodontitis

625

3217

1.24

5.97

1.3

6.12

6.31

mmol/l

1.02

580

3004

Sequelae of cerebrovascular disease

303

1919

1.35

5.90

1.3

1.4

6.73

6.22

mmol/l

1.82

294

1781

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

193

1331

1.46

5.86

1.4

1.3

6.70

6.24

mmol/l

1.66

175

1248

Exclusions for E4_PCOS_CONSORTIUM

335

1564

1.34

5.82

1.2

1.3

6.32

mmol/l

0.01

308

1470

Insulin, fast-acting (human)

462

1.78

5.79

1.3

1.4

10.84

5.76

mmol/l

17.91

433

Abnormal serum enzyme levels

253

1770

1.39

5.78

1.3

1.4

6.27

6.22

mmol/l

0.08

235

1645

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

426

1.82

5.77

1.3

1.4

6.02

6.16

mmol/l

0.16

403

Other infectious diseases

356

1.90

5.74

1.6

1.4

6.15

6.45

mmol/l

0.37

335

Diseases of the musculoskeletal system and connective tissue

307

1133

1.36

5.72

1.5

1.3

6.20

6.16

mmol/l

0.08

286

1057

Tuberculosis, wide

371

1.88

5.70

1.5

1.4

5.74

6.52

mmol/l

1.48

353

Malignant neoplasm of prostate

189

762

1.47

5.64

1.4

6.02

6.51

mmol/l

1.57

164

700

Tuberculosis, wide, including avohilmo

373

1.87

5.62

1.5

1.4

5.74

6.52

mmol/l

1.48

355

Other viral diseases, not elsewhere classified

102

615

1.66

5.59

1.3

1.4

6.15

6.26

mmol/l

0.16

580

Psychiatric diseases

612

2480

1.24

5.56

1.3

1.4

6.38

6.25

mmol/l

0.51

562

2332

Specific personality disorders

106

649

1.64

5.54

1.2

1.3

6.66

6.04

mmol/l

1.08

607

Statin medication

349

1489

1.32

5.48

1.4

1.3

6.71

5.65

mmol/l

9.14

323

1378

Malignant neoplasm of prostate, including Hilmo

191

774

1.46

5.48

1.4

5.96

6.49

mmol/l

1.79

166

711

Noninfective enteritis and colitis

272

2011

1.35

5.48

1.3

6.51

6.26

mmol/l

0.75

253

1857

Abdominal aortic aneurysm (AAA)

102

617

1.65

5.45

1.5

1.4

6.27

6.08

mmol/l

0.29

577

Childhood asthma (age<16), excluding more controls

2.98

5.39

1.1

1.0

5.54

6.37

mmol/l

1.17

Superficial injury of head

158

1066

1.49

5.38

1.3

1.4

6.27

6.28

mmol/l

0.01

146

991

Chronic diseases of tonsils and adenoids

249

2125

0.74

5.22

1.3

5.99

6.29

mmol/l

1.04

237

1980

Colectomy operation

128

834

1.54

5.20

1.2

1.4

6.51

6.33

mmol/l

0.30

119

778

Dorsalgia

599

2585

1.23

5.20

1.3

6.46

6.19

mmol/l

1.54

555

2410

Diabetic retinopathy, strict definition

130

753

1.54

5.16

1.4

10.09

7.23

mmol/l

13.47

123

685

Cholecystitis

112

710

1.59

5.14

1.4

6.36

6.29

mmol/l

0.09

105

651

Spondyloarthritis

114

726

1.58

5.11

1.4

6.18

6.30

mmol/l

0.18

104

681

Dizziness and giddiness

480

2997

1.25

5.08

1.4

1.3

6.51

6.26

mmol/l

1.26

445

2804

Fracture of foot, except ankle

134

887

1.52

5.06

1.3

6.53

6.19

mmol/l

0.78

117

829

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

122

781

1.55

5.04

1.3

6.30

6.16

mmol/l

0.21

110

738

Other viral diseases, not elsewhere classified, including avohilmo

131

858

1.52

5.03

1.3

6.13

6.17

mmol/l

0.06

118

802

Noninfectious colitis NAS

521

1.68

5.01

1.3

1.4

6.68

6.35

mmol/l

0.48

491

Alzheimer disease

172

1747

0.70

5.00

1.3

1.4

6.37

6.41

mmol/l

0.06

153

1645

Idiopathic pulmonary fibrosis

455

1.73

4.98

1.6

1.4

6.04

6.44

mmol/l

0.54

433

Cardiomyopathies, Secondary/extrinsic

6.22

4.97

1.3

1.5

6.52

5.65

mmol/l

0.32

Hernia of abdominal wall

301

2301

1.31

4.93

1.3

1.4

6.56

6.28

mmol/l

0.93

280

2134

Supplementary factors related to causes of morbidity and mortality classified elsewhere

188

1336

1.41

4.93

1.3

1.4

6.39

6.27

mmol/l

0.21

171

1240

Disorders of adult personality and behaviour

122

797

1.54

4.90

1.2

1.3

6.51

6.09

mmol/l

0.69

109

742

Systemic lupus erythematosus, unspecified

2.81

4.89

1.5

1.3

7.25

6.65

mmol/l

0.35

Open wound of ankle and foot

391

1.78

4.86

1.3

1.4

7.05

6.28

mmol/l

1.26

365

Pneumonitis due to solids and liquids

451

1.72

4.85

1.4

6.66

6.43

mmol/l

0.26

422

Other disorders of veins

246

1802

1.35

4.83

1.3

6.03

6.34

mmol/l

1.08

234

1672

Degenerative diseases of the nervous system

195

1938

0.72

4.82

1.2

1.4

6.24

6.39

mmol/l

0.36

174

1817

Type of accident

175

1240

1.42

4.69

1.3

1.4

6.35

6.28

mmol/l

0.10

159

1152

Other reaction to severe stress, and adjustment disorders

160

1114

1.44

4.68

1.4

1.3

6.43

6.19

mmol/l

0.56

149

1034

Other nutritional deficiencies

359

2580

1.27

4.65

1.3

6.63

6.22

mmol/l

2.01

332

2400

Childhood asthma (age<16)

2.72

4.64

1.1

1.0

5.54

6.46

mmol/l

1.41

Diaphragmatic hernia

246

1846

1.34

4.63

1.4

1.3

6.14

6.37

mmol/l

0.70

228

1714

Spondylopathies

509

2451

1.23

4.58

1.4

1.3

6.31

6.24

mmol/l

0.20

473

2285

Any mental disorder

665

2779

1.20

4.54

1.3

6.34

6.29

mmol/l

0.19

606

2620

Right hemicolectomy

298

1.87

4.53

1.3

1.4

6.05

6.58

mmol/l

0.78

282

Other diseases of liver

110

718

1.54

4.49

1.5

1.4

6.43

6.24

mmol/l

0.32

101

669

Personality disorders

116

766

1.52

4.48

1.2

1.3

6.58

6.09

mmol/l

0.81

102

712

Benign thyroid growths and nodules

196

1326

1.38

4.45

1.4

1.3

6.62

6.34

mmol/l

0.76

189

1238

Benign neoplasm: Ascending colon

111

729

1.53

4.43

1.6

1.4

6.66

6.32

mmol/l

0.62

101

673

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

633

1.57

4.42

1.3

1.4

6.50

6.33

mmol/l

0.31

593

Benign neoplasm: Rectum, anus and anal canal

151

1056

1.44

4.40

1.4

6.54

6.28

mmol/l

0.68

141

973

Disorder of lipoprotein metabolism, unspecified

613

1.58

4.34

1.4

1.3

7.08

6.15

mmol/l

2.09

563

Alzheimer’s disease, strict definition

131

1530

0.69

4.34

1.3

1.4

6.41

6.40

mmol/l

0.02

116

1449

Carcinoma in situ of skin of scalp and neck

178

2.12

4.31

1.4

1.5

7.28

6.41

mmol/l

0.38

170

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

111

733

1.52

4.30

1.2

1.4

6.54

6.29

mmol/l

0.52

105

682

Urinary track infection

248

931

1.34

4.23

1.3

6.43

6.26

mmol/l

0.43

226

876

Symptoms and signs involving the nervous and musculoskeletal systems

361

2883

1.25

4.22

1.3

6.35

6.29

mmol/l

0.15

339

2685

Anorexia

3.47

4.20

1.5

1.2

6.42

6.03

mmol/l

0.16

Viral and other specified intestinal infections, including avohilmo

123

802

1.48

4.19

1.3

6.43

6.16

mmol/l

0.69

112

745

Other dorsopathies, not elsewhere classified

597

2586

1.20

4.17

1.4

1.3

6.37

6.19

mmol/l

0.89

551

2411

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

532

3437

1.21

4.16

1.3

6.30

6.26

mmol/l

0.12

500

3198

Any prescribed medicine buy

+∞

4.15

1.8

0.0

5.74

—

mmol/l

—

Sleep apnoea

578

3041

1.20

4.14

1.3

6.47

6.24

mmol/l

1.08

529

2849

Alzheimer’s disease (Late onset)

123

1466

0.69

4.12

1.3

1.4

6.45

6.38

mmol/l

0.10

110

1387

Malignant neoplasm of rectum, including Hilmo

419

1.68

4.11

1.2

1.4

6.55

6.51

mmol/l

0.04

381

Procreative management

141

808

1.44

4.10

1.3

6.20

6.22

mmol/l

0.03

135

742

Other specified and unspecified personality disorders

243

1.90

4.10

1.2

1.4

6.15

6.16

mmol/l

0.01

226

Calcinosis cutis

10.86

4.10

1.3

1.0

5.83

7.71

mmol/l

—

Injuries to the elbow and forearm

399

2769

1.24

4.06

1.2

1.3

6.41

6.31

mmol/l

0.28

379

2569

Bicuspidal aortic valve syndrome

123

2.30

4.05

1.2

1.4

6.24

6.35

mmol/l

0.12

115

Adenocarcinoma and papilloma adenocarcinoma of rectum

332

1.76

4.01

1.2

1.3

6.78

6.63

mmol/l

0.16

297

Methotrexate

492

1.61

3.99

1.5

1.3

5.70

6.25

mmol/l

0.82

462

Umbilical hernia

174

1271

1.37

3.97

1.2

1.3

6.75

6.30

mmol/l

1.09

161

1166

Dementia

238

2118

0.77

3.96

1.2

1.4

6.31

6.35

mmol/l

0.06

218

1991

Viral and other specified intestinal infections

580

1.55

3.96

1.3

6.45

6.19

mmol/l

0.49

543

Retinal vascular disorders

652

1.53

3.95

1.4

6.71

6.25

mmol/l

0.81

601

Mycoses, including avohilmo

539

3428

1.20

3.94

1.3

6.40

6.25

mmol/l

0.54

504

3192

Obesity due to excess calories

243

1868

1.30

3.92

1.3

6.66

6.23

mmol/l

1.61

222

1738

Dermatophytosis

645

1.53

3.92

1.4

6.49

6.31

mmol/l

0.22

606

Unspecified nephritic syndrome

2.54

3.90

1.5

1.3

6.10

6.01

mmol/l

0.05

Malignant neoplasm of rectum

335

1.74

3.90

1.2

1.4

6.67

6.65

mmol/l

0.02

304

Listeriosis

5.50

3.88

1.5

1.4

6.20

6.05

mmol/l

—

Listeriosis, including avohilmo

5.49

3.88

1.5

1.4

6.20

6.05

mmol/l

—

Persons encountering health services for examination and investigation

396

1602

1.24

3.87

1.5

1.3

6.26

6.06

mmol/l

0.67

367

1494

Gastro-oesophageal reflux disease

402

2763

1.23

3.87

1.4

1.3

6.15

6.30

mmol/l

0.40

375

2580

Fracture of shoulder and upper arm

227

1730

1.31

3.87

1.3

1.4

6.64

6.34

mmol/l

0.73

214

1605

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

112

750

1.48

3.87

1.4

1.3

6.18

6.09

mmol/l

0.12

103

695

Other symptoms and signs involving cognitive functions and awareness

341

2423

1.25

3.86

1.3

1.4

6.60

6.27

mmol/l

1.34

312

2271

Cardiomyopathy due to drugs and other external agents

9.48

3.86

1.3

1.1

6.97

6.09

mmol/l

—

SLE, strict definition

101

2.40

3.83

1.5

1.3

7.24

6.39

mmol/l

0.61

SLE, ICD10

101

2.40

3.83

1.5

1.3

7.24

6.39

mmol/l

0.61

Retinal vascular occlusion

641

1.52

3.82

1.4

6.74

6.25

mmol/l

0.90

593

Abnormalities of gait and mobility

641

1.52

3.82

1.3

1.4

7.09

6.44

mmol/l

1.37

601

Degeneration of macula and posterior pole

373

2329

1.24

3.82

1.4

6.63

6.22

mmol/l

2.11

361

2167

Systemic lupus erythematosus

114

2.30

3.79

1.4

1.3

7.21

6.39

mmol/l

0.65

107

Sulfonylureas

279

1738

1.28

3.78

1.4

9.19

5.74

mmol/l

28.86

262

1629

Schizophrenia or delusion, excluding more controls

148

1050

1.39

3.74

1.2

1.3

6.03

6.29

mmol/l

0.50

130

981

Disorders of parathyroid gland

137

961

1.41

3.73

1.4

6.52

6.44

mmol/l

0.10

128

896

Infective dermatitis

494

1.59

3.71

1.4

6.51

6.25

mmol/l

0.32

464

Acute sinusitis

259

1836

1.28

3.71

1.3

6.10

6.19

mmol/l

0.19

241

1702

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

349

1.70

3.67

1.2

1.4

6.76

6.61

mmol/l

0.16

313

General examination and investigation of persons without complaint and reported diagnosis

380

1597

1.24

3.65

1.4

1.3

6.44

6.06

mmol/l

1.89

352

1489

Dementia, including avohilmo

259

2247

0.78

3.63

1.2

1.4

6.47

6.38

mmol/l

0.21

239

2111

Unknown and unspecified causes of morbidity

254

1.82

3.62

1.3

1.4

6.55

6.25

mmol/l

0.32

240

Lower back pain or/and sciatica

643

3411

1.17

3.60

1.3

6.41

6.26

mmol/l

0.63

598

3180

Benign neoplasm: Rectum

132

939

1.41

3.58

1.4

6.56

6.30

mmol/l

0.67

123

867

Zoster [herpes zoster]

129

914

1.42

3.58

1.4

6.34

6.40

mmol/l

0.08

123

849

Caries of enamel

372

2971

0.82

3.56

1.3

6.17

6.27

mmol/l

0.29

353

2758

Intestinal adhesions without obstruction

383

1.66

3.56

1.2

1.4

6.31

6.33

mmol/l

0.03

358

KRA_PSY_EATING, excluding more controls

116

2.23

3.55

1.1

1.3

6.77

5.81

mmol/l

0.58

108

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

10.47

3.54

1.3

1.2

5.08

7.03

mmol/l

—

Alcohol abuse, main dg, excluding more controls

564

1.53

3.53

1.2

1.4

6.58

6.30

mmol/l

0.32

530

Other and unspecified nonorganic psychotic disorders

540

1.54

3.52

1.3

1.4

5.69

6.17

mmol/l

0.86

512

Exclusions for E4_PCOS_BROAD

612

1.51

3.51

1.2

1.4

6.56

6.24

mmol/l

0.46

575

Obesity

326

2481

1.24

3.48

1.4

1.3

6.73

6.22

mmol/l

2.50

299

2309

Complications of internal orthopaedic prosthetic devices, implants and grafts

155

1140

1.36

3.45

1.5

1.3

6.69

6.35

mmol/l

0.76

149

1052

Medical observation and evaluation for suspected diseases and conditions

384

1602

1.23

3.42

1.4

1.3

6.27

6.06

mmol/l

0.67

358

1494

Diseases of pulp and periapical tissues, including avohilmo

634

2803

1.17

3.41

1.3

6.26

6.30

mmol/l

0.14

587

2618

Obesity and other hyperalimentation

327

2494

1.23

3.39

1.4

1.3

6.72

6.22

mmol/l

2.47

300

2321

Sequelae of injuries, of poisoning and of other consequences of external causes

129

924

1.40

3.38

1.4

6.27

mmol/l

0.00

116

858

Emotionally unstable personality disorder

253

1.78

3.36

1.3

6.77

6.13

mmol/l

0.51

234

Tubulo-interstitial nephritis, not specified as acute or chronic

246

1.80

3.36

1.5

1.4

8.00

6.11

mmol/l

2.84

231

Volvulus

134

2.12

3.35

1.3

1.4

5.81

6.69

mmol/l

1.01

126

Injuries to the knee and lower leg

704

3288

1.16

3.33

1.3

6.51

6.22

mmol/l

1.77

653

3066

Other strabismus

102

700

1.46

3.31

1.4

6.20

mmol/l

0.01

659

Disorders of the thyroid gland

567

3134

1.17

3.31

1.4

1.3

6.47

6.27

mmol/l

1.01

536

2907

Barrett oesophagus

241

1.80

3.28

1.4

5.56

6.41

mmol/l

1.15

228

Anxiety (asthma-related co-morbidities)

270

1633

1.26

3.25

1.3

6.26

6.17

mmol/l

0.19

247

1529

Inguinal hernia

388

2132

1.21

3.22

1.4

6.12

6.31

mmol/l

0.65

365

1977

L01XX Other antineoplastic agents

280

1.73

3.20

1.3

1.4

6.41

6.40

mmol/l

0.01

267

Benign neoplasm: Colon, unspecified

181

1382

1.31

3.17

1.4

6.78

6.31

mmol/l

1.40

159

1274

Symptoms and signs involving the skin and subcutaneous tissue

425

3365

1.19

3.17

1.3

6.20

6.31

mmol/l

0.43

400

3131

Schizophrenia or delusion

148

1098

1.35

3.15

1.2

1.3

6.03

6.27

mmol/l

0.45

130

1023

Hyperparathyroidism

120

852

1.40

3.13

1.4

6.57

6.44

mmol/l

0.17

113

793

Fracture of forearm

301

2195

1.23

3.12

1.2

1.3

6.50

6.29

mmol/l

0.64

287

2040

Other congenital malformations of respiratory system

8.07

3.12

1.2

1.4

6.27

8.06

mmol/l

—

Disorders of sphingolipid metabolism and other lipid storage disorders

7.78

3.08

1.2

1.4

7.25

5.99

mmol/l

—

Weight loss

470

1.54

3.08

1.4

6.15

6.37

mmol/l

0.24

444

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

301

2368

1.23

3.02

1.4

1.3

6.09

6.29

mmol/l

0.61

279

2203

Schizophrenia, schizotypal and delusional disorders

148

1106

1.34

3.02

1.2

1.3

6.04

6.29

mmol/l

0.48

130

1033

Episodal and paroxysmal disorders

629

2757

1.16

2.99

1.3

6.38

6.18

mmol/l

1.03

573

2572

Suicide or other Intentional self-harm

112

802

1.40

2.98

1.3

6.37

6.14

mmol/l

0.34

100

750

Benign neoplasm: Sigmoid colon

133

981

1.36

2.97

1.4

6.67

6.28

mmol/l

1.01

124

908

Cholecystectomy

435

3121

1.18

2.97

1.3

6.75

6.28

mmol/l

2.45

410

2912

Carcinoma in situ of skin of upper limb, including shoulder

148

1.99

2.97

1.2

1.5

7.14

6.56

mmol/l

0.20

142

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

122

887

1.38

2.97

1.3

6.30

6.07

mmol/l

0.39

110

826

Unspecified mental disorder

190

1479

1.29

2.90

1.2

1.3

6.32

6.28

mmol/l

0.06

171

1374

Zoster [herpes zoster], including avohilmo

325

2592

1.21

2.89

1.4

1.3

6.48

6.35

mmol/l

0.36

311

2415

Arthropathies

503

2166

1.17

2.88

1.4

1.3

6.19

6.31

mmol/l

0.43

465

2011

Disorders of eyelid, lacrimal system and orbit

530

3340

1.16

2.86

1.3

6.45

6.30

mmol/l

0.61

494

3113

Melanocytic naevi

160

1221

1.31

2.85

1.3

6.34

6.28

mmol/l

0.12

151

1130

Deep bite

255

0.38

2.84

1.3

1.4

5.97

6.15

mmol/l

0.13

237

Use of levodopa decarbox-comt-inhibitor

174

0.28

2.83

1.6

1.5

5.40

6.45

mmol/l

—

166

Spinal stenosis

354

2175

1.20

2.79

1.3

6.65

6.27

mmol/l

1.42

334

2029

Other anxiety disorders

192

1277

1.28

2.79

1.3

6.19

mmol/l

0.01

174

1183

Alzheimer’s disease (undefined), excluding more controls

0.00

2.78

0.0

1.4

—

6.36

—

Other diseases of oesophagus

466

1.51

2.77

1.7

1.3

5.96

6.40

mmol/l

1.01

440

Disorders of ocular muscles, binocular movement, accommodation and refraction

232

1845

1.25

2.77

1.3

6.22

6.23

mmol/l

0.02

214

1707

All anxiety disorders

273

1726

1.23

2.74

1.3

6.23

6.22

mmol/l

0.02

250

1602

Panic disorder

340

1.59

2.72

1.3

6.46

6.24

mmol/l

0.18

315

Herpesviral [herpes simplex] infections, including avohilmo

114

834

1.37

2.71

1.2

1.3

6.25

6.28

mmol/l

0.05

108

773

Dental operations

423

1840

1.18

2.70

1.4

1.3

6.10

6.41

mmol/l

1.71

393

1709

Nonalcoholic fatty liver disease

326

1.60

2.68

1.6

1.4

6.72

6.20

mmol/l

0.74

300

Alzheimer’s disease (Late onset), excluding more controls

701

0.68

2.67

1.2

1.4

6.50

6.19

mmol/l

0.49

660

Other/unspecified dorsalgia

213

1680

1.25

2.66

1.4

1.3

6.26

6.30

mmol/l

0.08

195

1566

Heartburn

414

1.53

2.65

1.3

6.68

6.35

mmol/l

0.46

386

Other and unspecified vascular occlusions

496

1.48

2.64

1.5

1.4

6.56

6.35

mmol/l

0.25

461

Other diseases of urinary system

596

2915

1.15

2.63

1.4

1.3

6.35

6.27

mmol/l

0.30

551

2716

Palmar fascial fibromatosis [Dupuytren]

120

891

1.35

2.62

1.4

1.3

6.92

6.20

mmol/l

1.29

112

823

Dorsopathies

587

2587

1.15

2.60

1.3

6.37

6.19

mmol/l

0.88

532

2412

Fluid overload

5.67

2.57

1.2

1.7

7.17

6.80

mmol/l

—

Burn and corrosion of other internal organs

7.39

2.57

1.4

1.0

4.38

5.97

mmol/l

—

Sleep apnoea, including avohilmo

584

3081

1.15

2.56

1.3

6.41

6.24

mmol/l

0.73

535

2883

Serous carcinoma of ovary

5.56

2.56

1.5

1.2

5.30

7.96

mmol/l

—

Other diseases of anus and rectum

195

1546

1.26

2.54

1.3

1.4

6.32

6.36

mmol/l

0.10

183

1438

Fibroblastic disorders

159

1235

1.29

2.53

1.4

1.3

6.77

6.20

mmol/l

1.38

150

1139

Kela-code for severe mental illness

172

1349

1.28

2.53

1.2

1.3

6.19

6.30

mmol/l

0.19

153

1256

Obesity, other/unspecified

156

1209

1.29

2.52

1.4

1.3

6.59

6.24

mmol/l

0.77

142

1129

Fall involving bed

172

1.82

2.51

1.2

1.4

7.65

6.60

mmol/l

0.98

166

Disorders of sclera, cornea, iris and ciliary body

302

2520

1.20

2.51

1.3

6.50

6.29

mmol/l

0.63

277

2350

Headache

296

1899

1.20

2.49

1.3

6.51

6.20

mmol/l

1.18

279

1761

Viral warts

309

1.59

2.49

1.4

5.95

6.31

mmol/l

0.45

290

Alcohol abuse, main dg

610

1.41

2.49

1.2

1.4

6.58

6.21

mmol/l

0.45

567

Dependence on enabling machines and devices, not elsewhere classified

3.01

2.49

1.4

5.95

6.68

mmol/l

0.48

Other systemic involvement of connective tissue (FG)

150

1138

1.30

2.48

1.3

6.23

6.43

mmol/l

0.45

140

1060

Other condition

544

1.44

2.48

1.3

1.4

5.89

6.26

mmol/l

0.54

511

Primary gonarthrosis, bilateral

257

2606

0.82

2.47

1.4

1.3

6.28

6.34

mmol/l

0.13

246

2423

Myocardial infarction, with ST-elevation

139

1066

1.31

2.46

1.4

6.89

6.37

mmol/l

1.40

126

975

Diseases of oral cavity, salivary glands and jaws

402

1762

1.18

2.44

1.4

6.34

6.35

mmol/l

0.03

372

1643

Gonarthrosis, primary, with knee surgery

295

2743

0.84

2.43

1.4

1.3

6.34

6.35

mmol/l

0.02

279

2552

Other and unspecified degenerative diseases of nervous system

159

0.31

2.43

1.2

1.5

5.50

6.41

mmol/l

—

153

Acute alcohol intoxication

156

1218

1.28

2.41

1.3

1.4

6.54

6.23

mmol/l

0.56

141

1124

Hyperosmolality and hypernatraemia

2.45

2.38

1.2

1.3

7.39

6.64

mmol/l

0.32

Schizophrenia

516

1.44

2.37

1.2

1.4

6.16

6.19

mmol/l

0.02

483

Acute alcohol intoxication, ICD10

112

838

1.34

2.36

1.3

1.4

6.22

6.18

mmol/l

0.05

102

780

Eating disorder

146

1.85

2.35

1.1

1.2

6.70

5.86

mmol/l

0.52

137

Keratitis

190

1524

1.25

2.35

1.2

1.3

6.50

6.29

mmol/l

0.52

175

1412

Strabismus

127

966

1.31

2.34

1.3

6.26

6.24

mmol/l

0.04

118

896

Speech therapy

152

1189

1.28

2.32

1.7

1.3

6.63

6.34

mmol/l

0.61

143

1098

Other and unspecified tonsillitis

120

753

1.33

2.31

1.4

1.3

6.04

6.03

mmol/l

0.01

110

696

Other disorders of urethra and urinary system

428

2568

1.16

2.31

1.3

6.33

6.27

mmol/l

0.18

395

2399

Other necrotizing vasculopathies

333

1.54

2.27

1.6

1.4

6.48

mmol/l

0.00

316

Acute suppurative otitis media

602

1.38

2.26

1.4

5.90

5.99

mmol/l

0.13

558

Sleep disorders (combined)

650

3011

1.13

2.23

1.3

6.40

6.23

mmol/l

0.78

602

2811

Other blood glucose lowering drugs, excl. Insulins

105

786

1.34

2.23

1.4

7.75

5.79

mmol/l

6.87

727

Other follicular disorders

225

1.65

2.20

1.4

6.75

6.35

mmol/l

0.50

209

Fall on and from stairs and steps

147

1154

1.28

2.20

1.4

1.3

6.10

6.34

mmol/l

0.43

140

1075

Tumor necrosis factor alpha inhibitors

433

1.46

2.19

1.5

1.4

5.27

6.09

mmol/l

1.34

404

Dermatitis and eczema

649

3415

1.13

2.19

1.4

1.3

6.24

6.29

mmol/l

0.17

604

3182

Hypothyroidism, strict autoimmune

400

2262

1.16

2.18

1.3

6.33

6.17

mmol/l

0.56

381

2104

Leisure time condition

100

746

1.34

2.18

1.3

1.4

6.65

6.25

mmol/l

0.59

703

Gingivitis and periodontal diseases

607

2774

1.13

2.17

1.3

6.23

6.37

mmol/l

0.63

558

2590

Ventral hernia

147

1157

1.27

2.17

1.4

1.3

6.35

6.31

mmol/l

0.08

136

1059

Acute upper respiratory infections

617

3280

1.13

2.17

1.4

1.3

6.44

6.25

mmol/l

0.75

578

3059

Collagenous colitis

370

1.49

2.15

1.3

1.4

6.84

6.46

mmol/l

0.40

352

Injuries to the shoulder and upper arm

506

3432

1.14

2.13

1.3

6.20

6.31

mmol/l

0.37

478

3194

Postmenopausal atrophic vaginitis

569

0.72

2.11

1.3

6.34

6.54

mmol/l

0.33

540

Polycystic kidney disease

2.02

2.11

1.7

1.4

6.35

6.52

mmol/l

0.10

Outcome of delivery

198

0.49

2.11

1.1

5.70

6.11

mmol/l

0.29

178

Diseases of salivary glands

168

1349

1.25

2.10

1.3

6.37

6.32

mmol/l

0.08

156

1254

Psoriasis

154

1226

1.26

2.08

1.4

1.3

6.20

6.34

mmol/l

0.30

143

1137

Right ventricular outflow tract obstruction

5.06

2.08

1.4

1.1

5.80

6.54

mmol/l

—

Bronchitis, not specified as acute or chronic

317

1.52

2.05

1.3

1.4

6.42

6.30

mmol/l

0.12

297

Retinal detachments and breaks

233

1941

1.20

2.05

1.3

6.76

6.16

mmol/l

2.36

223

1803

Retained placenta and membranes, without haemorrhage

289

0.48

2.05

1.2

1.3

5.76

6.23

mmol/l

0.64

267

Coxarthrosis [arthrosis of hip](FG)

356

2106

1.16

2.05

1.4

1.3

6.42

6.41

mmol/l

0.02

340

1956

Other and specified injuries of hip and thigh

1.98

2.01

1.3

6.93

6.22

mmol/l

0.57

Benign neoplasm of other and ill-defined parts of digestive system

109

836

1.31

1.99

1.4

6.54

6.41

mmol/l

0.24

100

777

Neurological diseases

458

2011

1.14

1.99

1.4

1.3

6.29

6.12

mmol/l

0.65

422

1879

Assault

352

1.48

1.98

1.3

1.4

5.77

6.13

mmol/l

0.37

332

Other systemic involvement of connective tissue

156

1252

1.25

1.98

1.3

6.18

6.34

mmol/l

0.35

146

1172

Biological medication for rheuma

502

1.40

1.97

1.4

5.44

6.10

mmol/l

1.03

468

Injuries to the ankle and foot

347

2560

1.16

1.94

1.3

6.56

6.18

mmol/l

1.50

319

2382

Any dementia, excluding more controls

215

1771

0.83

1.92

1.2

1.4

6.28

6.41

mmol/l

0.30

197

1669

Disease of hard tissues of teeth, NOS

261

1617

0.84

1.92

1.4

6.15

6.35

mmol/l

0.63

240

1507

!Aliquae complicationes praecoces traumatis

180

1.68

1.92

1.5

1.4

6.37

6.36

mmol/l

0.00

170

Early complications of trauma

180

1.68

1.92

1.5

1.4

6.37

6.36

mmol/l

0.00

170

Dental caries, including avohilmo

476

2144

1.14

1.91

1.4

1.3

6.16

6.36

mmol/l

0.95

438

2000

Fissure and fistula of anal and rectal regions

127

1000

1.27

1.91

1.3

6.17

6.33

mmol/l

0.34

120

924

Abnormal weight loss

439

1.42

1.90

1.4

6.07

6.34

mmol/l

0.29

416

Epilepsy

177

1445

1.22

1.88

1.3

1.4

6.30

6.23

mmol/l

0.11

161

1343

Missing teeth due to accident, extraction or parodontitis

385

3003

1.15

1.88

1.3

6.22

6.35

mmol/l

0.42

349

2810

Psoriasis vulgaris

103

792

1.30

1.87

1.5

1.4

6.05

6.22

mmol/l

0.30

735

Ulcer of oesophagus

342

1.47

1.85

1.6

1.4

6.38

6.40

mmol/l

0.02

322

Status epilepticus

167

1.69

1.84

1.2

1.4

6.62

6.41

mmol/l

0.16

156

Malignant neoplasm of vulva

3.57

1.84

1.5

1.2

5.22

7.35

mmol/l

—

Cystic kidney disease

115

1.84

1.83

1.8

1.3

6.30

6.49

mmol/l

0.12

107

Caries of dentine, including avohilmo

493

2231

1.13

1.82

1.4

1.3

6.11

6.36

mmol/l

1.34

452

2082

238

1727

1.19

1.81

1.3

1.4

6.79

6.28

mmol/l

1.96

230

1608

Diseases of inner ear

248

2782

0.85

1.78

1.3

6.64

6.32

mmol/l

1.10

235

2602

Erectile dysfunction

497

1.38

1.76

1.2

1.4

6.43

6.27

mmol/l

0.17

463

Anxiety disorders, excluding more controls

415

2332

1.14

1.76

1.3

6.26

6.29

mmol/l

0.07

388

2193

Soft tissue disorders related to use, overuse and pressure

158

1290

1.23

1.76

1.5

1.3

6.34

6.19

mmol/l

0.30

148

1197

Shoulder lesions

447

2369

1.13

1.73

1.3

6.30

6.27

mmol/l

0.08

413

2198

Disorders of skin appendages

230

1938

1.18

1.73

1.5

1.3

6.19

6.23

mmol/l

0.09

222

1792

Papulosquamous disorders

212

1784

1.19

1.73

1.4

1.3

6.16

6.36

mmol/l

0.59

197

1663

Injury of nerves and spinal cord at thorax level

3.92

1.72

1.6

1.2

7.20

6.75

mmol/l

—

Toxic effect of corrosive substances

3.91

1.72

1.0

1.3

6.40

5.68

mmol/l

—

Superficial injury of abdomen, lower back and pelvis

619

1.33

1.72

1.4

5.56

6.35

mmol/l

1.91

580

Any dementia

245

1986

0.85

1.72

1.3

1.4

6.19

6.38

mmol/l

0.53

226

1861

Other peripheral vascular diseases

282

1.50

1.71

1.3

6.47

6.22

mmol/l

0.31

267

Diseases of pulp and periapical tissues and dental caries

425

1921

1.14

1.71

1.4

1.3

6.16

6.38

mmol/l

0.98

395

1792

Chronic tubulo-interstitial nephritis

118

1.79

1.70

1.5

1.4

7.00

6.22

mmol/l

1.03

110

Alzheimer disease, excluding more controls

779

0.77

1.70

1.2

1.4

6.51

6.17

mmol/l

0.68

728

Chronic sinusitis

217

1830

1.19

1.70

1.5

1.3

6.06

6.37

mmol/l

1.11

203

1704

Other enthesopathy of foot (+metatarsalgia)

340

1.45

1.70

1.4

1.3

6.17

6.35

mmol/l

0.20

316

Depression or dysthymia

382

1828

1.14

1.69

1.4

6.58

6.19

mmol/l

1.51

356

1721

Papillary adenocarcinoma of thyroid gland

111

1.81

1.68

1.3

6.23

6.65

mmol/l

0.31

102

Combinations of oral blood glucose lowering drugs

173

1434

1.21

1.67

1.3

8.19

5.73

mmol/l

14.33

158

1334

Functional dyspepsia

132

1066

1.24

1.64

1.3

6.37

6.31

mmol/l

0.08

121

993

Other and unspecified effects of external causes

117

932

1.26

1.64

1.3

7.06

6.22

mmol/l

1.98

105

866

Contusion of ankle

105

1.82

1.63

1.6

1.3

6.33

6.49

mmol/l

0.07

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

335

1.44

1.62

1.4

6.75

6.29

mmol/l

0.54

314

Use of biperiden

190

1.59

1.60

1.1

1.4

5.40

6.51

mmol/l

1.34

177

Myalgia

114

912

1.25

1.56

1.3

6.21

6.15

mmol/l

0.07

109

849

Complications of labour and delivery

157

1055

0.83

1.56

1.2

1.3

6.23

6.30

mmol/l

0.15

143

994

Malignant neoplasm of anus and anal canal, including Hilmo

2.45

1.54

1.6

1.2

6.41

6.79

mmol/l

—

Nonorganic sleeping disorders, excluding more controls

648

1.30

1.54

1.3

5.87

6.23

mmol/l

0.70

609

Cystic kidney disease, including avohilmo

130

1.70

1.53

1.8

1.4

6.47

6.55

mmol/l

0.05

121

Presence of other devices

113

1378

0.81

1.52

1.3

6.99

6.18

mmol/l

2.50

105

1274

Oral lichen planus, including avohilmo , including avohilmo

245

0.53

1.52

1.5

1.4

5.99

6.42

mmol/l

0.19

230

Malignant neoplasm of vulva, including Hilmo

2.61

1.52

1.4

1.1

5.27

7.42

mmol/l

—

Urticaria and erythema

162

1349

1.20

1.52

1.3

6.35

6.25

mmol/l

0.21

143

1261

Acute appendicitis, with complications

106

845

1.26

1.51

1.5

1.4

6.60

6.26

mmol/l

0.51

788

169

1319

1.20

1.51

1.3

1.4

6.78

6.33

mmol/l

1.23

164

1230

Previous suicide attempt

2.88

1.51

1.3

1.2

6.83

6.05

mmol/l

—

Carcinoma in situ of skin of lower limb, including hip

109

1.76

1.47

1.2

1.4

7.07

6.61

mmol/l

0.44

104

Spondylosis

329

2265

1.14

1.47

1.4

1.3

6.35

6.25

mmol/l

0.22

310

2111

Faecal incontinence

352

1.40

1.45

1.2

1.3

6.01

6.50

mmol/l

0.54

333

Otosclerosis

316

0.60

1.44

1.3

1.5

6.53

6.33

mmol/l

0.23

299

Metatarsalgia

319

1.41

1.43

1.4

1.3

6.17

6.37

mmol/l

0.21

297

Infections with a predominantly sexual mode of transmission

787

1.26

1.43

1.3

6.29

6.08

mmol/l

0.31

732

Coxarthrosis

324

1844

1.13

1.40

1.4

1.3

6.38

6.43

mmol/l

0.14

308

1714

Voice disturbances

139

1152

1.21

1.40

1.4

1.3

6.04

6.37

mmol/l

0.73

129

1067

Dermatophytosis, including avohilmo

351

3058

1.13

1.40

1.3

6.39

6.22

mmol/l

0.49

332

2845

Lesion of sciatic nerve

224

0.53

1.38

1.3

1.4

5.27

6.55

mmol/l

1.53

215

Myeloid leukaemia

119

1.69

1.38

1.5

6.44

6.22

mmol/l

0.19

113

Carrier of infectious disease

1.84

1.36

1.0

1.3

7.70

6.24

mmol/l

—

Glucagon-like peptide-1 (GLP-1) analogues

151

1266

1.19

1.35

1.4

1.3

7.78

5.73

mmol/l

11.87

138

1174

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

151

1266

1.19

1.35

1.4

1.3

7.78

5.73

mmol/l

11.87

138

1174

Adverse effects, not elsewhere classified

635

1.28

1.35

1.3

1.4

7.40

6.26

mmol/l

2.12

595

Other abnormal uterine and vaginal bleeding

103

596

1.24

1.32

1.3

6.64

6.49

mmol/l

0.24

564

Conjunctivitis (acute, non atopic)

128

1055

1.21

1.32

1.3

6.37

6.29

mmol/l

0.09

120

979

Infections with a predominantly sexual mode of transmission, including avohilmo

126

952

1.21

1.31

1.2

1.3

6.20

6.07

mmol/l

0.21

119

888

Acute and transient psychotic disorders

351

1.37

1.30

1.3

1.4

6.14

6.26

mmol/l

0.12

331

Other keratitis

394

1.35

1.30

1.2

1.4

6.41

6.26

mmol/l

0.15

371

Benign neoplasm: Stomach

438

1.33

1.29

1.4

6.39

6.44

mmol/l

0.06

419

Bicipital tendinitis

174

0.52

1.29

1.3

1.4

4.96

6.30

mmol/l

—

161

Caught, crushed, jammed or pinched in or between objects

176

0.51

1.28

1.7

1.4

6.59

6.24

mmol/l

—

164

Fracture at wrist and hand level

168

1426

1.18

1.28

1.4

1.3

6.61

6.24

mmol/l

0.62

155

1309

Fall on same level involving ice and snow

309

2747

1.13

1.27

1.3

6.45

6.30

mmol/l

0.39

295

2550

Other disorders of bone

669

1.26

1.25

1.4

1.3

5.99

6.28

mmol/l

0.52

625

Varicose veins

363

2458

1.12

1.25

1.4

1.3

6.23

6.33

mmol/l

0.34

340

2290

Seborrhoeic keratosis

150

1268

1.19

1.25

1.3

6.12

6.30

mmol/l

0.32

145

1170

Dementia due to Parkinson's disease

159

0.50

1.25

1.0

1.5

4.35

6.46

mmol/l

—

152

Other disorders of ear

534

3152

1.09

1.25

1.3

6.43

6.26

mmol/l

0.60

503

2929

Dementia in other diseases classified elsewhere

265

0.60

1.23

1.0

1.4

5.38

6.49

mmol/l

1.11

249

Other symptoms and signs involving the nervous and musculoskeletal systems

217

1891

1.15

1.23

1.3

6.12

6.30

mmol/l

0.53

205

1755

Hidradenitis suppurativa

1.77

1.23

1.3

6.27

6.17

mmol/l

0.05

severe traumatic brain injury, does not include concussion

153

1300

1.18

1.21

1.3

1.4

6.70

6.30

mmol/l

0.96

140

1199

Postprocedural disorders of digestive system, not elsewhere classified

140

1.58

1.20

1.3

1.4

6.18

6.39

mmol/l

0.14

131

Other and unspecified aplastic anaemias

2.13

1.19

1.5

1.3

4.78

7.01

mmol/l

—

Neuromuscular dysfunction of bladder

427

1.32

1.19

1.3

1.4

6.32

6.35

mmol/l

0.03

399

Myocardial infarction, unclassifiable

171

1314

1.16

1.3

1.4

7.80

6.32

mmol/l

6.19

157

1216

Alzheimer’s disease (Atypical or mixed)

760

0.78

1.16

1.3

1.4

6.62

6.49

mmol/l

0.13

714

Other and unspecified urticaria

632

1.25

1.16

1.3

1.4

6.34

6.25

mmol/l

0.12

599

Hyperplasia of prostate

266

1324

1.13

1.15

1.4

6.28

6.20

mmol/l

0.19

244

1233

Parkinson's disease

903

0.80

1.15

1.4

6.04

6.37

mmol/l

0.48

839

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

377

1.33

1.15

1.2

1.5

6.75

6.39

mmol/l

0.39

358

Other crystal arthropathies

1.70

1.14

1.6

1.5

5.79

6.95

mmol/l

1.10

Benign neoplasm: Rectosigmoid junction

191

1.47

1.14

1.3

1.5

7.00

6.52

mmol/l

0.43

183

Neurotic, stress-related and somatoform disorders

424

2655

1.10

1.13

1.3

6.26

6.25

mmol/l

0.03

393

2469

Atopic dermatitis

188

1720

0.87

1.13

1.3

6.01

6.20

mmol/l

0.51

176

1601

Migraine, single triptan purchase ok & required. ICD-code if available is included

245

1875

0.88

1.13

1.2

1.3

5.87

6.27

mmol/l

2.01

232

1750

Triptan medication for migraine, single purchase ok

245

1875

0.88

1.13

1.2

1.3

5.87

6.27

mmol/l

2.01

232

1750

Unspecified chronic bronchitis

151

1.53

1.11

1.5

1.4

6.13

6.53

mmol/l

0.42

143

Melanocytic naevi of upper limb, including shoulder

1.72

1.11

1.4

1.3

6.25

6.42

mmol/l

0.07

Psoriatic and enteropathic arthropathies

414

1.31

1.11

1.6

1.4

5.92

6.26

mmol/l

0.54

385

Abnormalities of forces of labour

208

0.58

1.11

1.4

1.2

6.00

6.07

mmol/l

0.06

192

Neovascular glaucoma

184

1.47

1.11

1.3

1.4

7.11

6.17

mmol/l

0.87

174

Parkinson's disease, including avohilmo

931

0.80

1.11

1.4

6.11

6.38

mmol/l

0.38

863

Anxiety disorders

430

2689

1.10

1.09

1.3

6.25

6.26

mmol/l

0.01

399

2502

Demyelinating diseases of the central nervous system

226

1.42

1.09

1.2

1.4

5.36

6.20

mmol/l

1.11

210

Cushing syndrome

1.97

1.09

1.3

1.2

6.22

6.01

mmol/l

—

Pedal cyclist injured in transport accident

841

0.80

1.09

1.4

5.88

6.25

mmol/l

0.64

782

Fracture of skull and facial bones

105

873

1.20

1.09

1.2

1.3

6.02

6.15

mmol/l

0.20

810

Thyrotoxicosis with diffuse goitre

451

1.29

1.08

1.4

6.84

6.38

mmol/l

0.63

429

Glaucoma secondary to other eye disorders

185

1.47

1.08

1.3

1.4

7.11

6.35

mmol/l

0.64

177

Benign neoplasm of other and unspecified endocrine glands

549

1.26

1.08

1.4

6.26

6.31

mmol/l

0.06

517

Disorders of refraction and accommodation

113

943

1.19

1.08

1.3

6.16

6.18

mmol/l

0.03

104

880

Arthrosis

408

2033

1.10

1.07

1.3

6.15

6.39

mmol/l

0.95

372

1890

Diabetes mellitus in pregnancy

386

1.25

1.07

1.2

6.80

5.86

mmol/l

2.03

354

Other and unspecified disorders of vitreous body

183

2046

0.87

1.06

1.3

1.4

6.39

6.29

mmol/l

0.19

174

1905

Other intervertebral disc disorders

462

2522

1.09

1.06

1.4

1.3

6.37

6.22

mmol/l

0.57

428

2352

Early lumbar disc prolapse, operated

194

1.45

1.06

1.2

1.3

6.02

5.90

mmol/l

0.07

182

Postmenopausal bleeding

580

0.82

1.06

1.2

1.3

6.15

6.58

mmol/l

1.22

550

Disorders of lacrimal system

231

2015

1.13

1.05

1.3

6.70

6.34

mmol/l

1.11

215

1871

Radiculopathy

777

1.21

1.05

1.2

1.3

6.56

6.25

mmol/l

0.52

727

Dental pulpitis, including avohilmo

366

2578

0.91

1.05

1.3

6.33

6.22

mmol/l

0.30

336

2399

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.68

1.04

1.3

6.29

6.94

mmol/l

0.44

Other disorders of the musculoskeletal system and connective tissue

642

1.23

1.04

1.2

1.4

6.38

6.30

mmol/l

0.12

604

Symptoms and signs involving speech and voice

181

1584

1.14

1.02

1.4

1.3

6.01

6.33

mmol/l

0.85

170

1463

Viral conjunctivitis, including avohilmo

106

0.47

1.01

1.2

1.3

6.66

6.20

mmol/l

—

Nerve, nerve root and plexus disorders

609

3396

1.08

1.01

1.3

6.52

6.25

mmol/l

1.47

568

3162

Granulomatous disorders of skin and subcutaneous tissue

1.66

1.01

2.3

1.2

6.41

mmol/l

0.00

Iridocyclitis

111

937

1.19

1.00

1.3

6.27

6.30

mmol/l

0.03

873

Anterior Iridocyclitis

818

1.20

1.00

1.3

1.4

6.15

6.23

mmol/l

0.12

764

Single delivery by forceps and vacuum extractor

172

0.66

0.99

1.3

1.2

5.94

5.93

mmol/l

0.01

153

Erythema multiforme

1.72

0.99

1.6

1.4

6.45

6.12

mmol/l

0.26

HSIL lesion of the cervix uteri

343

1.31

0.99

1.2

1.3

6.05

6.01

mmol/l

0.03

318

Non-selective monoamine reuptake inhibitors

198

1676

1.13

0.99

1.3

6.42

6.32

mmol/l

0.17

183

1563

Alzheimer’s disease (Atypical or mixed), excluding more controls

529

0.79

0.98

1.3

1.4

6.64

6.28

mmol/l

0.42

502

Tonsillectomy and adenotomy

143

1152

0.86

0.98

1.2

1.3

5.98

6.08

mmol/l

0.18

134

1063

Generalized skin eruption due to drugs and medicaments

140

1.51

0.97

1.5

1.3

6.61

6.44

mmol/l

0.10

130

Disorders of oesophagus in diseases classified elsewhere

1.64

0.97

1.5

1.3

5.89

6.68

mmol/l

0.44

Viral warts, including avohilmo

748

1.20

0.97

1.3

1.4

5.85

6.26

mmol/l

0.88

697

Contraceptive management

102

847

0.84

0.96

1.4

1.3

5.83

6.21

mmol/l

1.06

767

Fitting and adjustment of other devices

187

1450

1.14

0.96

1.3

6.83

6.26

mmol/l

1.54

172

1334

Traumatic subdural haemorrhage

103

811

1.19

0.96

1.3

1.4

6.79

6.21

mmol/l

1.25

758

Polycystic ovarian syndrome, consortium definition

267

1374

1.11

0.95

1.3

1.2

6.31

6.33

mmol/l

0.06

247

1295

Hypothyroidism, other/unspecified

481

2920

1.08

0.95

1.4

1.3

6.34

6.26

mmol/l

0.30

455

2712

Other enthesopathies

142

1230

1.16

0.94

1.5

1.3

6.19

6.17

mmol/l

0.03

132

1138

Crystal arthropathies, rheuma endpoint

101

1.60

0.94

1.6

1.5

5.79

7.18

mmol/l

1.37

Acute and subacute iridocyclitis

760

1.20

0.94

1.3

1.4

6.24

6.26

mmol/l

0.02

711

Noise effects on inner ear

197

0.61

0.94

1.2

1.6

6.70

6.33

mmol/l

0.38

186

Monoamine oxidase A inhibitors

453

1.26

0.93

1.3

1.4

6.09

6.31

mmol/l

0.18

422

Other joint disorders

451

2166

1.09

0.93

1.4

1.3

6.21

6.31

mmol/l

0.35

416

2011

Postpartum care and examination

156

1.37

0.92

1.2

5.74

6.02

mmol/l

0.31

138

Lichen simplex chronicus

142

1.49

0.92

1.5

1.4

5.30

6.52

mmol/l

1.51

134

Embedded and impacted teeth

470

0.78

0.92

1.2

1.3

5.44

5.97

mmol/l

0.70

436

Gonarthrosis,primary

487

3167

0.93

0.92

1.4

1.3

6.16

6.36

mmol/l

0.86

457

2947

Bullous pemphigoid

118

1.54

0.91

1.8

1.5

6.35

6.56

mmol/l

0.13

113

Appendectomy

291

2512

1.10

0.91

1.3

6.06

6.26

mmol/l

0.68

266

2339

Migraine with aura

680

1.21

0.91

1.3

5.99

6.15

mmol/l

0.30

633

Adenocarcinoma and papillary adenocarcinoma of stomach

1.64

0.91

1.2

1.3

6.05

7.11

mmol/l

0.42

Other disorders of pigmentation

193

1.40

0.90

1.3

1.4

6.51

6.48

mmol/l

0.02

181

Unspecified urinary incontinence

360

0.72

0.90

1.3

1.4

7.22

6.39

mmol/l

0.76

339

Acute bronchiolitis

1.57

0.89

1.2

1.3

5.81

6.15

mmol/l

0.22

Myasthenia gravis

1.66

0.88

1.2

1.3

5.85

6.05

mmol/l

0.11

Benign neoplasm of other and unspecified female genital organs

127

0.55

0.88

1.1

1.2

5.40

6.36

mmol/l

—

119

Other surgical follow-up care

1.58

0.87

1.3

6.98

6.66

mmol/l

0.14

Rotator cuff syndrome

361

2280

1.09

0.87

1.3

6.20

6.28

mmol/l

0.22

331

2116

Etanercept

186

1.40

0.87

1.5

1.3

5.22

6.23

mmol/l

0.68

174

Anti-inflammatory and antirheumatic products, non-steroids

185

822

1.13

0.86

1.4

6.12

6.48

mmol/l

1.04

175

778

Urticaria

117

1007

1.16

0.86

1.3

6.23

6.29

mmol/l

0.09

105

937

Single delivery by caesarean section

225

0.73

0.86

1.1

1.2

6.15

5.94

mmol/l

0.34

200

Other and unspecified follicular disorders

153

1.44

0.85

1.4

6.95

6.25

mmol/l

0.76

140

Inguinal hernia, bilateral

622

1.21

0.85

1.6

1.4

6.39

6.25

mmol/l

0.13

568

Use of ropinirole

167

0.60

0.85

1.3

1.4

5.69

6.66

mmol/l

—

157

Polyuria

138

1205

1.15

0.85

1.4

6.18

6.28

mmol/l

0.17

124

1116

Other hearing loss

201

1741

1.12

0.85

1.4

6.60

6.34

mmol/l

0.68

193

1617

Other specified/unspecified hearing loss

442

1.25

0.84

1.3

1.4

6.33

6.43

mmol/l

0.12

420

Salpingitis and oophoritis

505

1.23

0.84

1.4

1.3

5.98

6.47

mmol/l

0.83

471

Coxibs

176

816

1.13

0.83

1.4

5.96

6.49

mmol/l

2.11

163

772

HSIL lesion of the cervix uteri, vagina or vulva

416

1.25

0.83

1.4

1.2

6.12

6.02

mmol/l

0.10

388

Benign neoplasm of brain and other parts of central nervous system

261

0.69

0.82

1.2

1.4

5.36

6.37

mmol/l

0.77

246

Maltreatment syndromes

105

1.53

0.81

1.1

1.3

5.95

6.19

mmol/l

0.28

Shoulder region

1.74

0.80

1.3

4.59

6.38

mmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

317

0.72

0.80

1.3

1.5

6.50

6.33

mmol/l

0.12

299

Otitis externa

108

932

1.16

0.79

1.3

1.4

6.76

6.26

mmol/l

1.08

870

Deforming dorsopathies

131

1146

1.14

0.79

1.4

1.3

6.26

6.31

mmol/l

0.07

121

1073

Colonic or urogenital fistula

134

1175

1.14

0.79

1.3

6.18

6.26

mmol/l

0.14

127

1086

Spermatocele

441

0.77

0.79

1.3

1.4

6.38

6.23

mmol/l

0.14

405

Focal epilepsy

108

933

1.16

0.78

1.3

1.4

6.10

6.35

mmol/l

0.50

101

866

Atopic dermatitis, strict definition with reimbursement

790

1.17

0.77

1.3

5.73

6.11

mmol/l

0.84

739

Injuries to the neck

102

879

1.16

0.77

1.4

5.98

6.23

mmol/l

0.59

820

Nonorganic sleeping disorders

714

1.18

0.75

1.3

1.4

5.87

6.18

mmol/l

0.57

672

Excessive attrition of teeth

228

2481

0.91

0.75

1.3

6.14

6.25

mmol/l

0.29

213

2301

Agoraphobia

1.70

0.75

1.3

1.2

6.54

6.35

mmol/l

—

Inflammatory bowel disease

139

1230

1.13

0.73

1.3

6.38

6.28

mmol/l

0.16

133

1136

Selective serotonin reuptake inhibitors

553

2699

1.07

0.73

1.3

6.45

6.24

mmol/l

0.84

512

2530

Other diseases of spinal cord

125

1.45

0.73

1.2

1.3

6.03

6.28

mmol/l

0.14

117

Carcinoma in situ of other and unspecified genital organs

1.68

0.72

1.9

1.2

6.22

6.28

mmol/l

—

Inguinal or femoral hernia, bilateral

635

1.18

0.72

1.6

1.4

6.39

6.26

mmol/l

0.11

580

Infective bursitis

117

1.46

0.72

1.3

1.4

6.17

6.18

mmol/l

0.00

110

Dissociative [conversion] disorders

1.55

0.72

1.5

1.2

5.82

6.36

mmol/l

0.42

Additional codes for the location of defect, injury or illness

220

1.32

0.71

1.6

1.4

5.88

6.49

mmol/l

0.61

208

Benign neoplasm: Skin of ear and external auricular canal

194

0.67

0.71

1.5

1.4

6.65

6.45

mmol/l

0.12

187

Ankle and foot

1.94

0.71

1.4

6.54

5.99

mmol/l

—

Diabetic neuropathy

652

1.18

0.70

1.3

1.4

8.65

7.48

mmol/l

2.05

596

Chondropathies

518

1.20

0.69

1.4

5.77

6.19

mmol/l

0.73

489

Moderate visual impairment, binocular

146

0.61

0.69

1.2

1.3

7.86

6.64

mmol/l

—

140

Striking against or struck by other objects

148

1319

1.12

0.69

1.2

1.3

6.18

6.22

mmol/l

0.05

133

1214

Sixth [abducent] nerve palsy

157

0.63

0.69

1.2

1.4

6.88

6.46

mmol/l

—

150

Suppurative and unspecified otitis media

125

977

1.13

0.69

1.3

6.16

6.14

mmol/l

0.03

119

904

Other osteochondropathies

222

1.31

0.68

1.6

1.4

5.79

6.29

mmol/l

0.46

208

Other congenital malformations of skin

119

0.59

0.67

1.9

1.3

8.30

6.30

mmol/l

—

108

Pain in joint

297

1684

1.08

0.67

1.4

1.3

6.28

6.13

mmol/l

0.36

275

1562

Endometriosis diagnosis and infertility diagnosis occurring together

205

1.32

0.67

1.1

1.3

5.85

6.23

mmol/l

0.33

192

Conductive and sensorineural hearing loss

473

2949

1.06

0.66

1.3

6.58

6.30

mmol/l

1.18

446

2742

Bipolar affective disorders

539

1.19

0.66

1.1

1.3

6.15

6.18

mmol/l

0.02

504

Corneal ulcer

715

1.16

0.66

1.2

1.4

6.85

6.28

mmol/l

1.14

664

Benign paroxysmal vertigo

127

1428

0.89

0.66

1.3

6.51

6.35

mmol/l

0.26

117

1325

Other headache syndromes

181

1634

1.10

0.66

1.3

6.26

6.20

mmol/l

0.11

170

1526

Visual disturbances and blindness

281

2595

1.08

0.65

1.3

6.51

6.30

mmol/l

0.75

269

2413

Visual disturbances

254

2339

1.09

0.65

1.3

6.43

6.28

mmol/l

0.43

244

2174

Hypothyreosis and Thyroxine purchase for inclusion criteria

495

3052

1.06

0.65

1.4

1.3

6.37

6.29

mmol/l

0.27

469

2839

Hyperfunction of pituitary gland

120

1.42

0.64

1.2

1.3

5.20

6.18

mmol/l

1.08

110

Other sleep disorders

486

1.20

0.64

1.3

1.4

6.05

6.25

mmol/l

0.20

456

Sciatica+with lumbago

267

2182

1.08

0.64

1.3

6.34

6.24

mmol/l

0.27

249

2035

Vasomotor rhinitis (mode)

281

0.75

0.64

1.4

6.88

6.39

mmol/l

0.26

265

Other congenital malformations of circulatory system

1.50

0.63

1.9

1.4

6.75

6.23

mmol/l

0.19

Other/unspecified enthesopathies of lower limb, excluding foot

225

1.29

0.63

1.6

1.4

5.82

6.22

mmol/l

0.41

216

Injury of muscle and tendon at shoulder and upper arm level

168

1853

0.91

0.63

1.4

5.71

6.34

mmol/l

2.95

156

1712

Disorders of vestibular function (Vertigo)

224

2373

0.92

0.62

1.3

1.4

6.65

6.35

mmol/l

0.86

211

2212

Acute nasopharyngitis (common cold)

330

1.23

0.62

1.3

6.14

6.26

mmol/l

0.09

299

Other hammer toe(s) (acquired)

771

0.86

0.62

1.4

1.3

6.14

6.49

mmol/l

0.61

724

Polyp of the female genital tract

621

0.87

0.62

1.4

1.3

6.17

6.51

mmol/l

0.73

588

Dislocation, sprain and strain of joints and ligaments of knee

222

2182

0.92

0.61

1.3

6.46

6.17

mmol/l

0.86

211

2025

Other sexually transmitted chlamydial diseases, including avohilmo

164

0.67

0.61

1.1

1.2

4.05

5.79

mmol/l

1.50

154

Injury of muscle and tendon at wrist and hand level

544

0.83

0.61

1.4

6.31

6.19

mmol/l

0.11

506

Parkinson's disease, excluding more controls

768

0.86

0.60

1.4

6.04

6.19

mmol/l

0.18

720

All dysplastic lesions of the cervix uteri

527

1.18

0.60

1.3

1.2

6.08

6.05

mmol/l

0.04

492

Early lumbar disc prolapse operation

227

1.28

0.59

1.2

1.3

6.00

6.05

mmol/l

0.03

210

Periapical abscess

220

2025

1.09

0.59

1.3

6.29

mmol/l

0.01

202

1876

Triptan medication for migraine, min. 3 purchases

150

1240

0.90

0.59

1.2

1.3

5.73

6.19

mmol/l

1.70

138

1160

Mixed connective tissue disease

1.57

0.59

1.5

1.3

5.44

6.15

mmol/l

—

Acetic acid derivatives and related substances

174

816

1.10

0.58

1.4

6.12

6.49

mmol/l

0.69

158

772

Extrapyramidal and movement disorders

195

2125

0.92

0.58

1.3

1.4

6.07

6.32

mmol/l

0.60

181

1978

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

217

1829

0.92

0.58

1.4

1.3

6.28

6.22

mmol/l

0.14

202

1696

Nonspecific lymphadenitis

173

0.69

0.57

1.8

1.4

5.28

6.30

mmol/l

0.58

160

Diseases of male genital organs

309

1449

1.07

0.57

1.4

1.3

6.39

6.14

mmol/l

0.78

286

1348

Lumbar disc prolapse

337

2336

1.07

0.57

1.4

1.3

6.47

6.22

mmol/l

0.83

314

2177

Conjunctivitis (acute, non atopic), including avohilmo

494

3146

0.95

0.56

1.3

6.19

6.31

mmol/l

0.45

459

2935

Vitamin deficiency

185

1.30

0.56

1.1

1.4

6.93

6.54

mmol/l

0.36

175

Vitamin deficiency, wide

185

1.30

0.56

1.1

1.4

6.93

6.54

mmol/l

0.36

175

Subjective visual disturbances

119

1067

1.12

0.56

1.3

1.4

6.52

6.33

mmol/l

0.36

114

990

Leiomyoma of uterus

237

1228

1.08

0.55

1.3

6.42

mmol/l

0.01

221

1156

Infections of genitourinary tract in pregnancy

206

0.73

0.55

1.3

5.43

6.09

mmol/l

0.56

192

Injuries to the wrist and hand

488

3409

0.95

0.55

1.3

6.22

6.28

mmol/l

0.15

459

3169

Nail disorders

284

1.23

0.55

1.8

1.4

6.88

6.34

mmol/l

0.53

264

Other specified/unspecified inflammatory spondylopathies

116

1.38

0.54

1.1

1.3

6.57

6.28

mmol/l

0.18

110

All dysplastic lesions of the cervix uteri, vagina or vulva

638

1.15

0.54

1.3

1.2

6.14

6.17

mmol/l

0.03

597

Early syphilis, including avohilmo

1.54

0.53

1.8

1.3

4.38

6.32

mmol/l

—

Other inflammation of eyelid, including avohilmo

159

1738

0.91

0.52

1.3

6.06

6.22

mmol/l

0.33

153

1614

Abnormal findings on examination of urine, without diagnosis

196

1.28

0.52

1.5

1.4

6.34

6.26

mmol/l

0.04

184

Focal epilepsy, mode (most common among epilepsy diagnosis)

826

1.13

0.52

1.3

1.4

5.94

6.36

mmol/l

1.00

770

Focal epilepsy, strict definition

883

1.12

0.52

1.3

1.4

6.21

6.37

mmol/l

0.29

818

Other disorders of eyelid

271

2389

1.07

0.52

1.3

1.4

6.38

6.32

mmol/l

0.14

252

2231

Other demyelinating diseases of the central nervous system

1.45

0.52

1.2

1.3

4.69

6.17

mmol/l

1.20

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

107

1175

0.90

0.51

1.4

1.3

6.21

6.17

mmol/l

0.04

101

1096

Other disorders of patella

575

0.85

0.50

1.3

6.19

6.21

mmol/l

0.01

537

Dermatitis herpetiformis

1.39

0.50

1.4

1.3

5.50

6.40

mmol/l

—

Other protozoal intestinal diseases, including avohilmo

1.39

0.50

1.4

1.3

6.48

6.40

mmol/l

—

Necrosis of pulp, including avohilmo

223

2368

0.93

0.50

1.3

6.12

6.21

mmol/l

0.17

204

2200

LSIL lesion of the vulva

1.50

0.49

1.3

1.1

6.29

6.52

mmol/l

—

Contact with heat and hot substances

180

1.28

0.49

1.2

1.4

7.07

6.32

mmol/l

0.96

169

Other disorders of lacrimal gland

177

1632

1.09

0.49

1.3

6.69

6.29

mmol/l

1.14

167

1519

Dermatitis due to substances taken internally

198

1.27

0.49

1.4

1.3

6.92

6.47

mmol/l

0.30

188

Stenosis and insufficiency of lacrimal passages

399

1.18

0.49

1.3

1.4

6.84

6.36

mmol/l

0.45

380

Unspecified dementia

696

0.88

0.49

1.3

1.4

5.89

6.46

mmol/l

1.09

652

Adenomyosis (Endometriosis of uterus)

454

1.17

0.49

1.4

1.3

6.07

6.46

mmol/l

0.46

430

Pollen allergy

403

1.17

0.48

1.3

6.18

6.03

mmol/l

0.18

375

Organic, including symptomatic, mental disorders

357

2372

1.06

0.48

1.3

1.4

6.49

6.35

mmol/l

0.43

329

2227

Uterine polyps

602

0.89

0.47

1.4

1.3

5.97

6.52

mmol/l

1.47

570

Disturbances of skin sensation

110

994

1.11

0.47

1.3

5.58

6.29

mmol/l

2.41

105

923

Trochanteric bursitis

592

0.86

0.47

1.4

1.3

6.64

6.41

mmol/l

0.24

551

Pilonidal cyst

218

1.24

0.46

1.3

5.34

6.03

mmol/l

0.63

201

Disorders of eyelid in diseases classified elsewhere

120

1.34

0.46

1.3

1.4

6.55

6.33

mmol/l

0.10

112

Ovarian cyst

127

660

1.10

0.46

1.3

1.2

6.28

6.42

mmol/l

0.28

117

624

Cyst of Bartholin Gland

1.39

0.46

1.2

5.58

6.35

mmol/l

0.65

Family history of certain disabilities and chronic diseases leading to disablement

1.39

0.46

1.2

1.3

6.05

6.35

mmol/l

0.16

Lactose intolerance

0.61

0.46

2.4

1.3

6.30

6.89

mmol/l

—

Urethritis and urethral syndrome

0.60

0.46

1.2

1.3

6.46

6.51

mmol/l

—

Undefined dementia

711

0.88

0.45

1.3

1.4

5.89

6.49

mmol/l

1.17

659

Anankastic personality disorder

1.43

0.45

1.4

1.2

6.01

6.32

mmol/l

0.26

Superficial injury of wrist and hand

696

0.88

0.45

1.3

1.4

6.16

6.11

mmol/l

0.04

652

Female infertility, tubal origin

0.59

0.45

1.2

1.3

7.66

6.29

mmol/l

—

Crohn's disease of large intestine

147

1.30

0.45

1.5

1.3

5.84

6.48

mmol/l

0.62

135

Sequelae of infectious and parasitic diseases

292

1.20

0.45

1.2

1.3

5.96

6.40

mmol/l

0.40

276

Female infertility

469

0.88

0.45

1.1

1.3

6.16

6.17

mmol/l

0.01

447

Artificial joint re-operation

320

1.19

0.44

1.4

6.51

6.49

mmol/l

0.02

305

Follow-up examination after treatment for conditions other than malignant neoplasms

217

1348

1.07

0.44

1.3

6.20

6.05

mmol/l

0.32

205

1255

Sequelae of other and unspecified infectious and parasitic diseases

157

1.28

0.43

1.1

1.3

5.99

6.34

mmol/l

0.21

147

Exposure to other and unspecified animate mechanical forces

1.41

0.43

1.3

6.90

6.15

mmol/l

0.43

Benign neoplasm: Skin of eyelid, including canthus

703

0.88

0.43

1.3

1.4

6.75

6.30

mmol/l

0.69

657

Helminthiases, including avohilmo

104

1.35

0.43

1.4

1.3

6.29

6.39

mmol/l

0.08

Adhesive capsulitis of shoulder

725

1.12

0.43

1.2

1.3

7.07

6.26

mmol/l

1.31

669

Isolated proteinuria

113

1.33

0.42

1.4

6.96

6.12

mmol/l

0.55

107

Noninflammatory disorders of female genital tract

123

676

0.91

0.42

1.3

1.2

6.18

6.40

mmol/l

0.51

116

640

Polyarthrosis

113

927

1.10

0.42

1.3

5.90

6.45

mmol/l

1.43

107

866

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glucose [Moles/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS